Any death

DEATH

sudden infant death syndrome: Sudden infant death syndrome (SIDS) is the unexpected, sudden death of a child under age 1 which cannot be explained after a thorough investigation is conducted. Infants who are affected by the condition generally appear healthy with no suspicious signs and symptoms prior to the incident. It is the leading cause of death in infants age 1 to 12 months old. The exact underlying cause of SIDS is unknown; however, scientists suspect that it is likely a multifactorial condition (associated with the effects of multiple genes in combination with lifestyle and environmental factors). Although there is no guaranteed way to prevent SIDS, the American Academy of Pediatrics has a published list of recommendationsfor risk reduction. Please click on the link to access this resource.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — ANY Cause of death: ICD-9 — ANY Cause of death: ICD-8 — ANY 1 out of 7 registries used, show all original rules.	78397
4. Check minimum number of events None	78397
5. Include endpoints None	78397
6. Filter based on genotype QC (FinnGen only)	76083

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF9

NAME	DEATH
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	ANY
COD_ICD_9	ANY
COD_ICD_8	ANY
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Any death based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (not available in FinRegistry).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	76083	25028	51055
Unadjusted period prevalence (%)	18.62	8.88	23.39
Median age at first event (years)	77.54	79.10	76.78

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
30741: Matched controls
220060

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

23.5

323.3

296

L01CB01

ATC

etoposide; systemic

15.6

323.0

346

160

SPAT1254

SPAT

Administration of medicine

1.9

323.0

4737

18860

L08

ICPC

Shoulder symptom/complaint

0.5

322.4

2608

37558

WX290

NOMESCO Finland

Other blockage of nerve

0.6

322.3

6695

71806

L01BC59

ATC

trifluridine, combinations; systemic

24.0

320.9

292

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

12.1

320.3

390

233

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.4

318.6

926

1557

A10BB12

ATC

glimepiride; oral

2.5

317.4

2323

6973

J01MA14

ATC

moxifloxacin; systemic

2.2

316.4

3029

10255

R74

ICPC

Upper respiratory infection acute

0.5

315.9

2982

40676

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

6.1

314.8

633

754

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.3

312.5

924

1575

R4110, ,

SPAT

0.2

311.6

318

14040

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

5.1

309.6

752

1081

N05BA06

ATC

lorazepam; systemic, sublingual

4.1

307.7

2366

4437

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

307.7

5539

22866

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.2

307.7

2244

5230

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

21.2

307.7

558

192

B01AA03

ATC

warfarin; systemic

1.9

307.7

6242

25824

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.0

307.7

921

1349

128

Kela drug reimbursment

Cancers of female genital organs

6.4

307.7

930

1068

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

66.3

307.7

411

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

7.7

307.7

727

689

K02.1

ICD-10 Finland

Caries of dentine

0.6

307.7

10271

102273

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

10.9

307.7

623

416

SDA02

NOMESCO Finland

Periodontal treatment, brief

0.5

307.7

4472

57626

SFA20

NOMESCO Finland

Two-surface restoration

0.5

307.7

9470

103820

K03.64

ICD-10 Finland

Dental calculus supragingival

0.4

307.7

3139

46644

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

33.2

307.7

285

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

6.1

307.7

680

814

L03AA13

ATC

pegfilgrastim; parenteral

4.1

307.7

2140

3903

N02AA01

ATC

morphine; systemic, rectal

14.3

307.7

1081

559

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.5

307.7

2675

8127

SAA01

NOMESCO Finland

Simple examination of mouth

0.5

307.7

13219

132869

J01MA12

ATC

levofloxacin; systemic

2.2

307.7

6843

25686

EB1VA, ,

NOMESCO Finland

0.0

307.7

18975

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

29.8

307.7

1721

437

TKC20

NOMESCO Finland

Catheterisation of bladder

2.6

307.7

2552

7421

N02AA05

ATC

oxycodone; systemic

7.6

307.7

12726

18686

N05AX08

ATC

risperidone; systemic

2.5

307.7

2517

7517

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

10.1

307.7

1267

932

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.3

307.7

1032

1759

SAA02

NOMESCO Finland

Basic examination of mouth

0.5

307.7

10996

118755

I50.0

ICD-10 Finland

Congestive heart failure

3.9

307.7

3058

6133

SFA30

NOMESCO Finland

Three-surface restoration

0.5

307.7

6735

75686

WF004

NOMESCO Finland

Palliative radiotherapy

15.5

307.7

1885

926

EB4VA, ,

NOMESCO Finland

0.0

307.7

13284

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.3

307.7

3808

12727

K70.0

ICD-10 Finland

Alcoholic fatty liver

11.1

307.7

485

317

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

13.5

307.7

3838

2297

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

307.7

3259

10945

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

16.8

307.7

893

392

D82

ICPC

Teeth/gum disease

0.5

307.7

4462

57758

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

15.9

307.7

463

212

Z51.5

ICD-10 Finland

Palliative care

28.8

307.7

9446

3342

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.2

307.7

8281

22569

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

37.3

307.7

951

188

A41.9

ICD-10 Finland

Sepsis, unspecified

5.8

307.7

1898

2481

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.8

307.7

867

1326

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.4

307.7

5110

72750

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

262.4

307.7

959

A06AD11

ATC

lactulose; oral

3.2

307.7

6277

16286

TJA10

NOMESCO Finland

Laparocentesis

32.6

307.7

271

C10AA07

ATC

rosuvastatin; oral

0.4

307.7

4197

62685

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

6.1

307.7

1499

1833

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

10.6

307.7

1144

797

A98

ICPC

Health maint/preventive medicine

0.1

307.7

21682

214036

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.2

307.7

4663

11626

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

15.3

307.7

2091

1043

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

75.0

307.7

352

D19

ICPC

Teeth/gum symptom/complaint

0.4

307.7

3005

43010

163

Kela drug reimbursment

Abiraterone and enzalutamide

9.0

307.7

541

438

XX3DW

NOMESCO Finland

Time consuming IT work

2.2

307.7

4214

14662

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

4.1

307.7

1954

3547

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

6.4

307.7

635

720

SFA10

NOMESCO Finland

One-surface restoration

0.5

307.7

8995

96812

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

307.7

4416

16020

D70.82

ICD-10 Finland

Drug-induced neutropenia

5.5

307.7

816

1085

R4190

NOMESCO Finland

Nutritional therapy

3.8

307.7

1485

2933

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

307.7

4598

18096

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

32.9

307.7

282

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

6.7

307.7

700

759

TPX10

NOMESCO Finland

Implantation of vascular injection port

7.5

307.7

2053

2081

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

19.9

307.7

860

318

JN4CD

NOMESCO Finland

Very extensive body CT

4.2

307.7

1885

3378

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

307.7

4343

15563

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.0

307.7

2144

5375

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.3

307.7

2327

5326

L01CA04

ATC

vinorelbine; systemic

18.6

307.7

728

286

192

Kela drug reimbursment

Fulvestrant

25.0

307.7

431

125

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

307.7

3857

13394

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

10.8

307.7

1620

1123

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.1

307.7

474

42924

C03DA01

ATC

spironolactone; oral

2.3

307.7

4492

15443

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

307.7

5222

16526

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

27.8

307.7

289

Z02.4

ICD-10 Finland

Examination for driving licence

0.4

307.7

3992

57184

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.7

307.7

943

1486

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.3

307.7

10874

31044

J96.1

ICD-10 Finland

Chronic respiratory failure

9.3

307.7

1159

927

R83

ICPC

Respiratory infection other

0.3

307.7

1555

30374

M25.5

ICD-10 Finland

Pain in joint

0.5

307.7

3925

51152

A03FA01

ATC

metoclopramide; systemic, rectal

4.4

307.7

11510

26322

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

307.7

16107

84522

176

Kela drug reimbursment

Regorafenib

49.8

307.7

262

A10AE04

ATC

insulin glargine; parenteral

2.3

307.7

3531

11521

WX892

NOMESCO Finland

Monitored bed care

3.1

307.7

3407

8533

M79.6

ICD-10 Finland

Pain in limb

0.5

307.7

6576

73782

J94.8

ICD-10 Finland

Other specified pleural conditions

7.0

307.7

869

911

M01AE01

ATC

ibuprofen; systemic, rectal

0.6

307.7

21980

179731

L82

ICD-10 Finland

Seborrhoeic keratosis

0.3

307.7

1697

32082

L15

ICPC

Knee symptom/complaint

0.4

307.7

2795

41136

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

8.7

307.7

813

685

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

18.5

307.7

811

321

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

45.6

307.7

378

Z01.2

ICD-10 Finland

Dental examination

0.4

307.7

5949

77145

M05BX04

ATC

denosumab; parenteral

2.6

307.7

2446

7203

WW200, ,

SPAT

0.1

307.7

932

42276

Z2446

NOMESCO Finland

Social worker

3.1

307.7

2252

5457

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

5.1

307.7

1685

2457

R98

ICD-10 Finland

Unattended death

71.6

307.7

248

A04AA02

ATC

granisetron; systemic, transdermal

6.8

307.7

4589

5572

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

21.1

307.7

720

250

R01AD12

ATC

fluticasone furoate; nasal

0.5

307.7

3239

45090

A10AC01

ATC

insulin (human); parenteral

3.7

307.7

2879

6005

H02AB02

ATC

dexamethasone; systemic

7.9

307.7

8755

10577

WX730

NOMESCO Finland

Conventional respirator

7.0

307.7

828

872

J96.0

ICD-10 Finland

Acute respiratory failure

7.9

307.7

612

564

A04AA01

ATC

ondansetron; systemic, rectal

5.9

307.7

5223

7351

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

5.7

307.7

1697

2246

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

7.7

307.7

570

536

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.3

307.7

1728

3949

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

8.3

307.7

874

769

ZX090

NOMESCO Finland

Other technic of radiotherapy

3.7

307.7

1196

2388

ZXD05

NOMESCO Finland

Urgent procedure

2.1

307.7

9884

41240

I51.7

ICD-10 Finland

Cardiomegaly

37.4

307.7

285

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.7

307.7

3200

8965

130

Kela drug reimbursment

Malignant tumour

11.8

307.7

8182

6588

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.1

307.7

796

1137

L02BA03

ATC

fulvestrant; parenteral

16.6

307.7

461

202

L01AX03

ATC

temozolomide; systemic

19.0

307.7

626

240

N05CF01

ATC

zopiclone; oral

1.7

307.7

10327

49529

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

5.6

307.7

1171

1547

C03CA01

ATC

furosemide; systemic

3.2

307.7

13367

42389

A06AH03

ATC

naloxegol; oral

21.0

307.7

1355

482

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

10.6

307.7

709

491

A79

ICPC

Malignancy NOS

6.5

307.7

850

956

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.6

307.7

1183

1911

A04AD12

ATC

aprepitant; systemic

5.2

307.7

1031

1470

L01BC06

ATC

capecitabine; oral

6.5

307.7

2761

3268

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.9

307.7

3252

6457

R50.9

ICD-10 Finland

Fever, unspecified

2.3

307.7

5218

18166

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

4.7

307.7

1035

1633

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

307.7

7497

33005

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

4.1

307.7

1310

2345

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

6.3

307.7

984

1157

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

12.7

307.7

4424

2873

R03BB04

ATC

tiotropium bromide; inhalant

2.3

307.7

3551

11746

OAB43, ,

SPAT

0.1

307.7

340

24109

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

6.4

307.7

688

783

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

8.5

307.7

904

783

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

10.9

307.7

1365

938

A96

ICPC

Death

29.3

307.7

312

A28

ICPC

Limited function/disability NOS

2.4

307.7

6819

23313

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

307.7

5733

20679

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

25.9

307.7

343

369

Kela drug reimbursment

Regorafenib

49.7

307.7

255

B03XA02

ATC

darbepoetin alfa; parenteral

5.4

307.7

1013

1375

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.3

307.7

1700

33979

K83.1

ICD-10 Finland

Obstruction of bile duct

6.1

307.7

700

840

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

0.6

307.7

9687

100189

WF049

NOMESCO Finland

Radiotherapy of metastasis

15.7

307.7

3525

1804

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

3349.1

307.7

468

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.8

307.7

2086

3272

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

11.9

307.7

1055

654

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.6

307.7

6052

67765

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.7

307.7

1749

3502

L03

ICPC

Low back symptom/complaint

0.5

307.7

3430

45021

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.7

307.7

6421

11723

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

17.0

307.7

3622

1718

GBB00

NOMESCO Finland

Tracheostomy

7.4

307.7

587

579

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

16.9

307.7

422

181

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

8.1

307.7

562

506

R01AD58

ATC

fluticasone, combinations; nasal

0.4

307.7

1799

32722

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

8.1

307.7

804

730

M01AH05

ATC

etoricoxib; oral

0.5

307.7

10508

116678

N05BA04

ATC

oxazepam; oral

1.8

307.7

7824

35291

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.4

307.7

2048

35874

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.4

307.7

2635

43978

AA1BD

NOMESCO Finland

Extensive CT of head and brain

4.3

307.7

1176

2013

A10AB05

ATC

insulin aspart; parenteral

3.0

307.7

3050

7679

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

8.3

307.7

685

601

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.3

307.7

4020

9617

SDA03

NOMESCO Finland

Periodontal treatment

0.4

307.7

4638

67532

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.2

307.7

2090

4910

C56

ICD-10 Finland

Malignant neoplasm of ovary

49.5

307.7

510

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.1

307.7

1910

4587

AA1AD

NOMESCO Finland

CT of head and brain

1.8

307.7

9607

44688

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

307.7

3613

12689

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.1

307.7

3242

8032

A04AA55

ATC

palonosetron, combinations; systemic

4.1

307.7

1542

2768

OAA67, ,

SPAT

0.1

307.7

155

12750

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.8

307.7

3336

9153

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

6.0

307.7

685

831

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.5

307.7

6349

77812

A10BB01

ATC

glibenclamide; oral

3.9

307.7

1143

2141

L03AA02

ATC

filgrastim; parenteral

5.5

307.7

1722

2351

JAH00

NOMESCO Finland

Laparotomy

4.1

307.7

1177

2119

JN4BD

NOMESCO Finland

Extensive body CT

4.5

307.7

6321

12057

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

7.1

307.7

1028

1062

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.4

307.7

3549

8166

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

307.7

7879

32312

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

8.3

307.7

568

497

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.1

307.7

1809

4315

JDB10

NOMESCO Finland

Percutaneous gastrostomy

8.0

307.7

741

675

ZX120

NOMESCO Finland

Intravenous

3.4

307.7

4374

10143

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.1

307.7

1187

2146

N03AX14

ATC

levetiracetam; systemic

3.9

307.7

1261

2358

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

349.0

307.7

621

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

3.0

307.7

2371

5916

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

16.3

307.7

845

381

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.7

307.7

8962

22008

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

9.5

307.7

624

479

TK800

NOMESCO Finland

Hemodialysis

5.3

307.7

1078

1495

N05AD01

ATC

haloperidol; systemic

5.6

307.7

1370

1805

I50.9

ICD-10 Finland

Heart failure, unspecified

3.1

307.7

5731

15039

JN4AD

NOMESCO Finland

Body CT examination

3.0

307.7

5153

13713

SPAT1109

SPAT

Analgesia with portable analgesic pump

39.8

307.7

520

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

8.6

307.7

551

468

WW500

NOMESCO Finland

Blood transfusion

8.6

307.7

2816

2560

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.7

307.7

1542

3082

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.5

307.7

1469

2004

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

18.6

307.7

3723

1617

R18

ICD-10 Finland

Ascites

12.9

307.7

1527

887

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.1

307.7

2356

5808

C20

ICD-10 Finland

Malignant neoplasm of rectum

23.2

307.7

586

184

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.9

307.7

1716

3258

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.1

307.7

2720

6729

WX872

NOMESCO Finland

Intensive care

2.6

306.0

2084

6036

WX882

NOMESCO Finland

High dependency care

3.6

305.6

1128

2273

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

22.0

302.2

283

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.8

301.5

1710

4500

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

4.2

300.7

907

1571

OAB48, ,

SPAT

0.1

300.6

150

11572

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

14.7

297.8

328

161

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.5

296.6

3469

44214

L03AA14

ATC

lipegfilgrastim; parenteral

4.5

296.5

833

1361

A41.8

ICD-10 Finland

Other specified sepsis

4.5

293.5

809

1301

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.4

292.1

662

891

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.3

292.0

749

18368

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

4.1

286.8

890

1576

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

38.6

286.2

230

SDA01

NOMESCO Finland

Periodontal treatment, very brief

0.5

284.2

3065

40208

C01AA05

ATC

digoxin; systemic

2.4

283.9

2290

7181

C10AX09

ATC

ezetimibe; oral

0.4

283.2

1858

29195

G12.2

ICD-10 Finland

Motor neuron disease

13.3

282.1

327

178

B01AB10

ATC

tinzaparin; parenteral

2.0

281.2

3525

13227

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

15.9

281.2

299

136

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

89.6

280.2

199

A10AA02, ,

ATC

3.8

279.5

967

1859

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

15.3

278.9

302

143

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

6.7

278.8

515

558

A10AB01

ATC

insulin (human); parenteral

3.6

277.3

1032

2090

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

9.5

276.9

391

298

OAA65, ,

SPAT

0.1

275.4

249

12067

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.5

274.3

2832

37765

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.6

274.0

7464

75781

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

5.4

273.9

618

828

B01AB05

ATC

enoxaparin; parenteral

1.6

271.9

10363

53579

V03AE01

ATC

polystyrene sulfonate; oral

5.8

271.7

578

730

K02.0

ICD-10 Finland

Caries limited to enamel

0.3

271.2

1119

21550

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.2

270.9

1237

2866

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.3

270.6

2336

7545

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.4

270.4

2120

6557

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

6.2

269.4

534

626

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

9.4

268.7

382

294

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

5.7

267.5

577

739

OAB42, ,

SPAT

0.2

267.4

457

14309

M04AA01

ATC

allopurinol; systemic

1.9

267.0

4366

17921

K92.0

ICD-10 Finland

Haematemesis

3.9

266.8

893

1675

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

19.1

266.0

262

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2.7

265.7

1670

4636

205

Kela drug reimbursment

Chronic hypertension

1.6

265.6

8634

42924

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.7

265.6

1625

4448

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

265.5

8680

43212

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

5.9

265.0

548

672

GD1AA, ,

SPAT

0.2

264.9

369

13200

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

15.0

263.6

288

139

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.8

261.9

915

1771

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.6

261.8

968

1951

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.3

261.3

602

823

I50.1

ICD-10 Finland

Left ventricular failure

2.7

261.0

1594

4358

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

700.4

259.3

291

A10AD05

ATC

insulin aspart; parenteral

5.1

256.9

618

880

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.6

256.9

964

1963

1XC07, ,

NOMESCO Finland

28.1

255.8

222

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

7.2

255.7

443

445

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.5

255.3

1798

5282

R01AD09

ATC

mometasone; nasal

0.6

255.1

7292

73603

WZC00, ,

SPAT

0.2

254.6

515

14562

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

253.7

1437

3772

N05CD07

ATC

temazepam; oral

1.9

251.7

3681

14543

SPAT1229

SPAT

Assessment of need for aid

2.1

251.4

2671

9392

R84

ICPC

Malignant neoplasm bronchus/lung

14.8

250.5

275

134

L89

ICD-10 Finland

Decubitus ulcer and pressure area

4.4

249.8

717

1192

L13

ICPC

Hip symptom/complaint

0.5

249.5

2247

31545

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

4.4

248.8

721

1208

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

11.7

247.1

307

190

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.2

246.7

1130

2621

1CD01, ,

NOMESCO Finland

28.8

246.1

212

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

6.3

245.8

481

556

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

245.6

8114

40347

1501

Kela drug reimbursment

Palbociclib

9.8

245.3

339

250

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

19.6

245.0

239

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.5

244.6

1731

5095

WPB10

NOMESCO Finland

Making a convalescent care decision

15.5

243.8

262

122

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

6.5

243.2

460

512

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

4.6

242.1

654

1033

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

8.2

241.7

377

331

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

241.3

3866

15724

N05AH03

ATC

olanzapine; systemic

2.4

239.7

1801

5453

I21.0

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

19.3

239.4

235

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

109.3

239.2

167

A10AE05

ATC

insulin detemir; parenteral

2.5

238.7

1730

5149

M03BX02

ATC

tizanidine; oral

0.7

238.5

12612

112416

L02BX03

ATC

abiraterone; oral

8.6

238.0

360

303

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

237.3

4816

21046

K70.4

ICD-10 Finland

Alcoholic hepatic failure

12.9

236.9

278

155

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

236.6

9141

47055

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.1

235.7

732

1296

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

17.9

235.5

238

E86

ICD-10 Finland

Volume depletion

3.6

233.3

865

1746

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

233.2

3111

11889

N18.8

ICD-10 Finland

Other chronic renal failure

3.4

232.8

930

1975

A12BA01

ATC

potassium chloride; oral

2.9

231.4

1244

3170

N02BF01

ATC

gabapentin; oral

0.2

231.0

367

12095

H02

ICPC

Hearing complaint

0.4

230.4

1585

24665

TQW40, ,

SPAT

0.2

229.7

291

11147

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

239.6

229.4

267

I21.2

ICD-10 Finland

Acute transmural myocardial infarction of other sites

61.2

229.0

170

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.7

226.7

1419

3924

Z71.8

ICD-10 Finland

Other specified counselling

0.6

226.5

4371

48936

NHQ40

NOMESCO Finland

Amputation of toe

4.3

226.1

659

1109

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

18.9

225.6

223

N05AA02

ATC

levomepromazine; systemic

2.8

224.7

1291

3412

A11CC03

ATC

alfacalcidol; systemic

3.5

223.8

858

1772

N18.0

ICD-10 Finland

End-stage renal disease

6.1

223.5

447

529

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.1

223.5

1047

2461

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

9.9

223.0

307

225

SPAT1255

SPAT

Intravenous administration of medicine

2.1

222.8

2297

7967

S82

ICPC

Naevus/mole

0.4

222.7

1125

19908

R11

ICD-10 Finland

Nausea and vomiting

2.1

222.3

2508

9009

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.0

221.4

2790

10440

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

9.4

220.2

312

239

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

3.6

218.3

821

1673

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

217.8

2157

7359

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

11.9

217.3

267

162

L01XE33

ATC

[U] palbociclib

13.9

217.1

246

128

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

217.1

2072

6963

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

217.0

2086

7030

I25.2

ICD-10 Finland

Old myocardial infarction

2.3

216.9

1958

6428

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

5.0

216.2

534

779

394

Kela drug reimbursment

Palbociclib

9.3

216.1

308

238

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

7.7

215.7

353

330

ZX112

NOMESCO Finland

Subcutaneous

3.6

215.5

815

1667

NFQ20

NOMESCO Finland

Amputation of femur

9.3

214.9

308

240

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

9.0

214.7

313

250

M54.5

ICD-10 Finland

Low back pain

0.6

214.1

5624

58554

L02BB04

ATC

enzalutamide; oral

5.8

212.7

450

565

K65.0

ICD-10 Finland

Acute peritonitis

5.6

211.3

464

605

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

14.1

211.1

237

121

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.9

211.1

713

1345

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

15.7

210.9

225

103

ZX070

NOMESCO Finland

Intensity modified radiotherapy

3.6

210.5

787

1597

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.5

210.5

1503

4436

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

209.8

6759

33197

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.5

206.2

1504

4483

N03AG01

ATC

valproic acid; systemic, rectal

2.3

206.2

1731

5503

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.8

205.8

1193

3166

N17.8

ICD-10 Finland

Other acute renal failure

4.7

205.5

535

818

L01

ICPC

Neck symptom/complaint

0.4

205.2

1429

22226

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

204.9

10776

58781

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

29.8

203.8

174

Z3226

NOMESCO Finland

Physiotherapist

1.6

203.2

5375

25127

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

203.1

7586

38493

R06AX27

ATC

desloratadine; oral

0.6

203.0

3292

38823

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

6.0

202.9

413

498

198

Kela drug reimbursment

Sorafenib

25.9

202.7

180

SPAT1088

SPAT

Blood transfusion

9.4

202.4

288

222

A12AA04

ATC

calcium carbonate; oral

4.3

202.2

596

1012

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

200.7

10283

55739

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

15.4

200.6

216

101

OAA80, ,

SPAT

0.1

200.4

7449

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

39.7

200.3

160

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.3

199.4

762

15384

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

28.6

198.1

171

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

4.6

198.0

534

842

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

6.4

197.0

379

430

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

6.7

196.2

360

387

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

16.4

195.8

205

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

0.5

195.5

2583

32362

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

27.8

195.4

170

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

195.1

1860

6240

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

7.9

194.2

313

287

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

42.3

194.0

153

S18

ICPC

Laceration/cut

0.7

193.5

9739

89188

N05AH04

ATC

quetiapine; oral

1.7

193.2

4392

19705

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

5.6

192.4

416

534

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

20.9

192.3

183

ZX095

NOMESCO Finland

Combined chemoradiotherapy

6.3

191.9

371

423

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.5

191.9

1403

4185

NG1AA, ,

SPAT

0.1

191.5

7116

A10AD01

ATC

insulin (human); parenteral

5.0

191.2

468

677

SPAT1290

SPAT

Preparation of deceased person

44.7

190.8

149

X70

ICD-10 Finland

Intentional self-harm by hanging, strangulation and suffocation

44.7

190.8

149

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

16.0

190.7

202

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

7.6

190.2

315

299

A46

ICD-10 Finland

Erysipelas

1.7

190.1

4663

21340

L01XE04

ATC

[U] sunitinib

21.5

189.8

179

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

13.9

189.2

214

111

WX110

NOMESCO Finland

Infiltration anesthesia

0.7

189.0

15870

132947

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.3

188.6

554

938

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

21.4

188.4

178

L17

ICPC

Foot/toe symptom/complaint

0.6

188.3

4718

50006

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

187.6

5901

28712

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

5.8

187.0

395

495

B01AB04

ATC

dalteparin; parenteral

2.2

186.6

1699

5588

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.6

185.2

1205

3394

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.6

184.8

687

1388

197

Kela drug reimbursment

Sunitinib

11.3

184.8

233

148

OAB44, ,

SPAT

0.2

184.5

245

9140

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

28.1

184.4

160

R4110

NOMESCO Finland

Physiotherapy

1.5

184.4

8349

43965

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

15.5

184.4

198

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.9

184.2

962

2408

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

184.2

2008

7101

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.6

183.9

3458

39369

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.8

183.9

637

1224

XW000

NOMESCO Finland

Bone marrow biopsy

2.4

183.5

1420

4348

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

6.8

183.4

334

356

D77

ICPC

Malignant digestive neopl other/NOS

9.2

182.8

263

206

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

0.7

182.6

8314

77893

Z3231

NOMESCO Finland

Registered nurse

1.5

182.2

7978

41704

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.2

181.5

827

1909

H02AB06

ATC

prednisolone; systemic

1.4

181.5

13876

80635

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

12.4

181.5

218

127

191

Kela drug reimbursment

Erlotinib

67.8

180.1

132

N05BA01

ATC

diazepam; systemic, rectal

1.7

180.0

3788

16613

WZC30, ,

SPAT

0.2

178.7

184

8200

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

3.3

178.2

754

1661

TDA90, ,

SPAT

0.2

178.2

182

8161

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.8

178.2

611

1165

JAL30

NOMESCO Finland

Omentectomy

4.7

178.1

473

736

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

24.1

177.5

161

OAB50, ,

SPAT

0.2

176.7

212

8483

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

4.1

176.6

541

947

WZC30

NOMESCO Finland

Teaching

1.6

176.1

5038

23920

SCA01

NOMESCO Finland

Preventive oral health care, short

0.6

175.7

3531

39602

ZX121

NOMESCO Finland

Central venous catheter

10.5

175.2

232

160

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

13.3

175.1

202

109

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

35.5

174.7

143

K70.1

ICD-10 Finland

Alcoholic hepatitis

6.8

174.6

318

339

D76

ICPC

Malignant neoplasm pancreas

15.1

174.0

189

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

2.9

173.9

901

2245

E87.5

ICD-10 Finland

Hyperkalaemia

3.6

173.6

644

1299

N02AJ06

ATC

codeine and paracetamol; systemic

0.7

173.5

8006

75059

K76.7

ICD-10 Finland

Hepatorenal syndrome

28.4

173.4

150

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

173.3

1300

3922

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

14.1

172.9

194

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.3

172.8

380

10333

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

0.4

172.5

1263

19376

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.1

172.4

541

965

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

16.9

172.0

178

M05BA02

ATC

clodronic acid; systemic

14.5

170.5

189

B03XA01

ATC

erythropoietin; parenteral

6.1

168.6

338

401

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.6

168.4

1068

2968

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

168.3

4839

22976

9440/3-C71.9

ICD-O-3

Glioblastoma, NOS, of brain, NOS

59.9

167.8

125

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

0.6

167.2

4070

43667

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

22.0

166.8

156

SPAT1234

SPAT

Support of social functional capacity

2.2

166.6

1563

5200

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

8.1

166.4

263

235

TJD20

NOMESCO Finland

Change of gastrostomy tube

10.5

166.1

219

150

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

165.9

1697

5847

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

7.4

165.5

279

271

352

Kela drug reimbursment

Abiraterone and enzalutamide

6.0

165.3

335

402

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.2

164.9

721

1622

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.7

164.0

580

1131

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

163.7

4200

19376

R41.0

ICD-10 Finland

Disorientation, unspecified

2.7

163.2

957

2552

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

2.6

162.7

1095

3134

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

162.7

1809

6437

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.9

162.4

874

2224

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

162.0

2367

9277

SPAT1262

SPAT

Handing over of treatment supplies

1.5

161.9

5517

27221

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.3

161.6

358

9706

H13

ICPC

Plugged feeling ear

0.6

161.1

2949

33988

X45

ICD-10 Finland

Accidental poisoning by and exposure to alcohol

12.4

161.0

193

112

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

12.6

160.8

191

109

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.8

160.4

904

2360

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

5.0

160.2

396

578

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

160.1

3363

14708

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

8.0

159.6

253

227

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.5

159.4

620

1292

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

0.2

159.1

271

8618

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

5.2

159.0

375

524

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.8

158.9

410

622

B03BA03

ATC

hydroxocobalamin; parenteral

2.1

158.8

1656

5747

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.6

158.6

428

675

NGQ20

NOMESCO Finland

Amputation of lower leg

8.2

158.3

246

215

ZYC01, ,

SPAT

0.3

158.2

517

11346

M01AB05

ATC

diclofenac; systemic, rectal

0.7

158.1

14835

124085

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

12.3

157.9

190

111

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

157.6

5225

25604

WZB00, ,

SPAT

0.2

157.4

274

8596

A10AA01, ,

ATC

3.2

157.2

698

1585

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

157.0

2019

7572

J01FA10

ATC

azithromycin; systemic

0.7

156.9

10793

94967

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

0.6

156.3

3499

38395

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

6.3

156.1

305

352

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

321.1

155.9

179

WF002

NOMESCO Finland

Radical radiotherapy

2.0

155.8

2003

7511

L57.0

ICD-10 Finland

Actinic keratosis

0.5

155.7

1225

18351

WYA20

NOMESCO Finland

Home visit

3.8

155.4

534

1020

ZZA00

NOMESCO Finland

Split skin graft

2.7

154.4

950

2598

C45.0

ICD-10 Finland

Mesothelioma of pleura

17.8

154.3

156

UJK02

NOMESCO Finland

ERCP

2.8

153.8

882

2324

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.2

153.6

684

1556

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.4

153.2

630

1362

M70.6

ICD-10 Finland

Trochanteric bursitis

0.5

153.2

1434

20215

KMAK, ,

NOMESCO Finland

0.7

153.2

9318

83815

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

8.6

153.0

231

194

159

Kela drug reimbursment

Pazopanib

16.1

152.5

161

R21

ICPC

Throat symptom/complaint

0.5

152.5

1856

24041

C10AA05

ATC

atorvastatin; oral

0.7

152.5

9486

85029

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.0

152.2

1849

6794

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.3

151.7

638

1400

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

5.0

151.6

369

531

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

21.4

151.6

143

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.5

151.5

1094

3239

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

3.5

151.3

591

1235

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.9

151.1

2137

8278

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.1

151.0

707

1659

R05

ICPC

Cough

0.6

150.1

3499

38086

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

150.1

3565

16096

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

149.9

2015

7671

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

39.2

149.8

120

TGC00

NOMESCO Finland

Bronchial lavation

2.7

149.6

900

2432

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

6.6

149.6

277

301

R03DA04

ATC

theophylline; systemic, rectal

2.3

149.6

1261

4006

TK810

NOMESCO Finland

Hemofiltration

6.2

149.3

296

347

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.6

148.5

972

2743

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.0

148.4

473

854

TGA30

NOMESCO Finland

Thoracocentesis

5.9

147.5

303

369

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

9.3

147.5

211

164

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

0.5

147.4

1485

20446

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

8.4

147.3

226

194

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

0.7

147.1

8699

78815

DFF00

NOMESCO Finland

Pure tone audiometry

0.4

146.9

1057

16393

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

0.6

146.9

4329

44747

WPA13

NOMESCO Finland

Palliative consultation

10.2

146.7

197

139

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

19.2

146.6

144

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

8.7

146.1

218

180

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

5.0

145.9

354

508

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.9

145.6

368

548

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.4

145.3

1143

3520

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

6.5

145.1

273

302

ZX050

NOMESCO Finland

Stereotactic radiotherapy

5.0

145.1

357

519

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.1

144.2

441

771

F05.9

ICD-10 Finland

Delirium, unspecified

3.1

144.1

671

1569

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

143.8

3974

18624

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

143.4

1643

5905

F03

ICD-10 Finland

Unspecified dementia

2.6

143.0

954

2717

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.3

142.9

599

1311

G41.9

ICD-10 Finland

Status epilepticus, unspecified

7.2

142.7

248

250

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

20.8

142.7

136

S12

ICPC

Insect bite/sting

0.4

142.4

727

12963

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

5.8

142.2

297

368

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.9

142.0

357

529

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

5.3

141.3

323

438

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

10.0

141.3

192

138

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.0

141.2

708

1730

AN1

Coronary angiography

1.6

140.8

3490

15913

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

0.6

140.7

4321

44352

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.9

140.5

290

355

L01XE05

ATC

[U] sorafenib

46.1

140.3

109

Z10.0

ICD-10 Finland

Occupational health examination

0.2

139.9

187

6978

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

13.9

139.2

157

L12

ICPC

Hand/finger symptom/complaint

0.5

139.1

1888

23733

N19

ICD-10 Finland

Unspecified kidney failure

2.4

139.0

1079

3302

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

3.0

138.9

674

1615

E87.6

ICD-10 Finland

Hypokalaemia

2.4

138.7

1099

3395

H29

ICPC

Ear symptom/complaint other

0.5

138.6

1259

17978

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

12.3

138.0

166

K86.0

ICD-10 Finland

Alcohol-induced chronic pancreatitis

35.3

137.9

113

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

137.5

1402

4818

C16.2

ICD-10 Finland

Malignant neoplasm: Body of stomach

71.8

137.4

100

OAB95, ,

SPAT

0.1

137.1

5188

C90.0

ICD-10 Finland

Multiple myeloma

4.3

136.7

401

678

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.0

136.3

672

1626

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

3.8

135.5

468

897

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.2

135.5

600

1360

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.5

135.3

1252

17775

K86

ICPC

Hypertension uncomplicated

0.5

135.1

1793

22708

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

2.8

134.4

769

2023

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.6

134.2

2786

31301

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

134.1

147

M54.4

ICD-10 Finland

Lumbago with sciatica

0.6

133.3

2252

26669

8160/3-C22.1

ICD-O-3

Cholangiocarcinoma of intrahepatic bile duct

35.6

133.3

109

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

0.6

132.9

2718

30658

A02BC02

ATC

pantoprazole; systemic

1.4

132.8

20291

129079

EB1AA, ,

SPAT

0.3

132.6

331

8414

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

132.3

145

S97

ICPC

Chronic ulcer skin

1.9

131.7

1925

7528

A97

ICPC

No disease

0.6

131.3

2444

28233

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

3.2

130.9

577

1304

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.5

130.7

1273

17776

158

Kela drug reimbursment

Everolimus

23.8

130.5

119

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

13.6

129.8

148

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

10.5

129.8

171

117

JDE00

NOMESCO Finland

Gastrojejunostomy

16.4

129.2

135

F10.24

ICD-10 Finland

Alcohol depence active use

3.4

129.0

517

1099

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

20.3

128.8

124

WX900

NOMESCO Finland

Resuscitation

8.8

128.5

190

155

Z01.7

ICD-10 Finland

Laboratory examination

0.5

128.3

1702

21586

G30.8

ICD-10 Finland

Other Alzheimer disease

3.2

127.8

567

1287

L01XE21

ATC

[U] regorafenib

+∞

127.7

140

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.6

127.7

343

539

Z75.5

ICD-10 Finland

Holiday relief care

13.1

127.4

148

8041/3-C34.1

ICD-O-3

Small cell carcinoma, NOS, of upper lobe, lung

40.3

126.8

101

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

19.4

126.7

124

S72.0

ICD-10 Finland

Fracture of neck of femur

2.3

126.6

1027

3205

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.3

126.5

1031

3224

VALMI, ,

NOMESCO Finland

0.6

126.5

3135

33846

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.6

126.5

2030

24408

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

8.1

126.4

198

175

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

4.4

126.2

357

586

WF003

NOMESCO Finland

Adjuvant radiotherapy

2.2

126.0

1154

3794

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.9

125.9

1828

7129

A10AB04

ATC

insulin lispro; parenteral

2.6

125.8

813

2278

I50

ICD-10 Finland

Heart failure

2.5

125.7

903

2665

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

11.4

125.1

157

N07BB01

ATC

disulfiram; oral

2.1

125.0

1246

4241

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.0

124.9

401

728

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.6

124.9

822

2325

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

124.7

1142

3755

L28

ICPC

Limited function/disability (L)

1.5

124.3

5191

26559

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

7.5

123.9

208

201

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

7.6

123.7

205

195

R03BB01

ATC

ipratropium bromide; inhalant

2.4

123.4

909

2714

WVA30, ,

SPAT

0.3

123.4

314

7905

N06AB04

ATC

citalopram; systemic

1.5

123.3

5399

27877

N40

ICD-10 Finland

Hyperplasia of prostate

0.7

123.3

3861

39660

1CD02, ,

NOMESCO Finland

4.6

123.0

330

518

A69.2

ICD-10 Finland

Lyme disease

0.3

123.0

352

8313

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

0.5

122.9

1067

15517

D01BA02

ATC

terbinafine; oral

0.7

122.6

4481

44643

SGA01

NOMESCO Finland

Emergency treatment

0.5

122.5

1629

20669

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

8.1

122.4

192

170

K92.1

ICD-10 Finland

Melaena

2.0

122.3

1556

5801

SPAT1312

SPAT

General health counselling

0.7

122.1

5408

51986

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

121.8

1476

5409

H3603, E113,

ICD-10 Finland

4.6

121.0

322

502

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

10.9

121.0

156

103

RS220, ,

NOMESCO Finland

3.9

120.9

404

756

N03AX16

ATC

[U] pregabalin

1.4

120.8

6718

36250

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

7.3

120.8

206

203

K05.30

ICD-10 Finland

Periodontitis complex

0.6

120.7

1930

23255

HA1RA, ,

SPAT

0.1

120.5

4353

G47.3

ICD-10 Finland

Sleep apnoea

0.7

120.3

3756

38637

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

6.1

120.1

238

279

M01AC06

ATC

meloxicam; systemic, rectal

0.7

119.3

6841

62963

N05AF03

ATC

chlorprothixene; systemic

2.6

119.2

741

2036

J43.9

ICD-10 Finland

Emphysema, unspecified

3.4

119.1

489

1056

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

16.5

118.8

124

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

15.3

118.7

128

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.0

118.7

582

1403

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.6

118.7

445

904

Angiography of the heart and coronary arteries

1.9

118.7

1647

6324

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

6.9

118.7

212

221

K72.9

ICD-10 Finland

Hepatic failure, unspecified

6.4

118.4

225

252

J80

ICD-10 Finland

Adult respiratory distress syndrome

10.1

117.9

159

113

I46.1

ICD-10 Finland

Sudden cardiac death, so described

39.7

117.6

EB1SA, ,

SPAT

0.2

117.6

148

5765

RS221, ,

NOMESCO Finland

3.5

117.5

452

935

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

117.4

1802

7151

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.7

117.3

682

1809

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.0

116.4

580

1412

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

116.1

10080

58435

P15

ICPC

Chronic alcohol abuse

2.4

116.0

866

2602

N05BA02

ATC

chlordiazepoxide; systemic

2.6

115.9

763

2158

SPAT1153

SPAT

Removal of sutures

0.7

115.8

6391

59274

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.7

115.8

688

1846

C09CA06

ATC

candesartan; oral

0.7

115.8

3856

39200

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

0.6

115.7

2666

29346

K03.00

ICD-10 Finland

Approximal wear

0.3

115.6

391

8475

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

115.3

8675

49174

L01XE11

ATC

[U] pazopanib

21.2

115.1

109

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.5

115.0

1428

18518

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

0.7

115.0

3518

36395

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

8.4

114.8

176

151

C02EA02, ,

ATC

2.1

114.7

1145

3898

SFA00

NOMESCO Finland

Small restoration

0.5

114.3

1581

19865

A07AA02

ATC

nystatin; oral

1.9

113.7

1687

6621

SPAT1167

SPAT

Insertion of urinary catheter

2.3

113.6

975

3117

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

10.5

113.6

150

103

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.5

113.5

443

925

Z01.1

ICD-10 Finland

Examination of ears and hearing

0.6

113.5

1885

22519

SGB30

NOMESCO Finland

Other complicated root filling

0.4

113.4

830

12856

348

Kela drug reimbursment

Roflumilast

10.0

113.2

154

111

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.9

113.1

367

672

N02AX02

ATC

tramadol; systemic, rectal

1.3

112.7

12537

75278

ZX080

NOMESCO Finland

Image guided radiotherapy

2.7

112.5

694

1899

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

112.5

1224

4308

G72.8

ICD-10 Finland

Other specified myopathies

3.1

112.3

511

1178

ZX122

NOMESCO Finland

Intra-arterial

10.9

112.3

145

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

0.4

112.1

766

12180

S29

ICPC

Skin symptom/complaint other

0.6

112.0

2964

31652

EC1VA, ,

NOMESCO Finland

0.0

111.6

3854

C34.0

ICD-10 Finland

Malignant neoplasm: Main bronchus

137.6

111.4

134

R01AD08

ATC

fluticasone; nasal

0.7

110.7

4314

42605

5BX04, ,

NOMESCO Finland

33.0

110.5

H43.8

ICD-10 Finland

Other disorders of vitreous body

0.5

110.3

1044

14769

C16.0

ICD-10 Finland

Malignant neoplasm: Cardia

120.4

110.2

134

K56.7

ICD-10 Finland

Ileus, unspecified

3.0

110.1

553

1352

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

10.4

110.1

146

101

SPAT1125

SPAT

Stoma care and guidance

3.0

110.0

540

1303

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.7

109.9

653

1752

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

109.8

1378

5110

N07XX02

ATC

riluzole; oral

20.0

109.7

106

SPAT1043

SPAT

Audiometry

0.5

109.6

1320

17292

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.1

109.5

500

1155

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

5.6

108.5

236

305

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.6

108.5

702

1968

M53.1

ICD-10 Finland

Cervicobrachial syndrome

0.5

108.5

1016

14428

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.6

108.4

403

814

M79.1

ICD-10 Finland

Myalgia

0.6

108.4

1548

19293

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

108.3

977

3190

155

Kela drug reimbursment

Afatinib and gefitinib

19.8

108.3

105

3AC01, ,

NOMESCO Finland

4.1

108.0

333

586

C16.00

ICD-10 Finland

Cardia

12.1

107.8

131

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.6

107.6

400

808

H81

ICPC

Excessive ear wax

0.6

107.5

2816

30172

T93

ICPC

Lipid disorder

0.4

107.4

576

10102

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

5.3

107.0

245

333

K04.5

ICD-10 Finland

Chronic apical periodontitis

0.7

106.9

4686

45348

X41

ICD-10 Finland

Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

57.4

106.6

K08.80

ICD-10 Finland

Toothache NOS

0.4

106.4

574

10045

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

7.3

106.4

181

178

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.8

106.4

363

690

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

5.7

106.3

227

288

NH3AA, ,

SPAT

0.1

106.1

3821

JFB00

NOMESCO Finland

Partial resection of small intestine

3.0

106.0

534

1308

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

2.1

106.0

1086

3734

R05

ICD-10 Finland

Cough

0.7

105.9

3280

33930

JLC30

NOMESCO Finland

Pancreatoduodenectomy

5.1

105.9

250

350

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

4.1

105.7

326

574

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.0

105.0

332

596

R33

ICD-10 Finland

Retention of urine

1.7

105.0

2223

9687

8140/3-C16.0

ICD-O-3

Adenocarcinoma, NOS, of cardia, NOS

13.5

104.6

120

P06

ICPC

Sleep disturbance

0.5

104.6

1124

15268

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.0

104.4

335

608

DAX08

NOMESCO Finland

Fitting of hearing aid

0.3

104.3

418

8355

EBA05

NOMESCO Finland

Complicated extraction of tooth

0.7

104.1

3271

33752

C07AB07

ATC

bisoprolol; oral

1.3

104.0

14684

90739

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

8.7

104.0

155

128

C07AB02

ATC

metoprolol; systemic

1.4

103.6

5477

29173

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

29.0

103.5

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.0

103.2

505

1216

R03DX07

ATC

roflumilast; oral

10.2

103.0

138

K80

ICPC

Cardiac arrhythmia NOS

0.5

102.5

834

12449

A10BK03

ATC

empagliflozin; oral

0.5

102.3

1212

15978

NA3BG, ,

SPAT

0.1

102.2

3850

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

102.2

4883

25528

F51.0

ICD-10 Finland

Nonorganic insomnia

0.6

101.7

1509

18633

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.0

101.7

1293

4814

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.6

101.4

375

755

M19.0

ICD-10 Finland

Primary arthrosis of other joints

0.5

101.4

1207

15890

N07BC02

ATC

methadone; systemic

7.2

101.4

174

173

J86.9

ICD-10 Finland

Pyothorax without fistula

4.1

101.4

308

536

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

11.4

101.3

127

Kela drug reimbursment

Transplant complication

2.9

101.1

512

1258

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

4.0

101.1

325

591

R01AD59

ATC

mometasone, combinations; nasal

0.0

100.9

3393

8070/3-C15.9

ICD-O-3

Squamous cell carcinoma, NOS, of esophagus, NOS

15.5

100.8

108

TGD00

NOMESCO Finland

Needle biopsy of lung

5.4

100.7

224

296

E87.2

ICD-10 Finland

Acidosis

5.2

100.7

236

328

L90

ICPC

Osteoarthrosis of knee

0.4

100.7

653

10614

S21

ICPC

Skin texture symptom/complaint

0.6

100.4

1988

22766

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.5

99.9

1303

16696

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

33.1

99.8

M01AE02

ATC

naproxen; oral, rectal

0.8

99.6

11528

96640

C34.96

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary microcellular carcinoma

36.3

99.5

N02AA03

ATC

hydromorphone; systemic, rectal

8.4

99.4

152

130

ZXC40

NOMESCO Finland

Use of ultrasound

4.6

99.4

264

411

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

7.4

99.3

168

164

N03AF01

ATC

carbamazepine; oral, rectal

1.9

99.0

1323

5011

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

23.9

99.0

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.8

98.8

250

373

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.8

98.7

337

641

X77

ICPC

Malignant neopl genital female other

8.4

98.3

150

128

SPAT1324

SPAT

Screening procedure

0.5

98.0

1029

14099

XX7FT

NOMESCO Finland

Radioyttrium therapy with connected antibody

20.5

98.0

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.1

98.0

448

1036

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

0.7

98.0

3458

34930

A10BK01

ATC

dapagliflozin; oral

0.5

97.9

738

11334

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.8

97.9

1572

6318

H3603, E103,

ICD-10 Finland

4.2

97.9

295

510

I71.0

ICD-10 Finland

Dissection of aorta [any part]

269.4

97.9

113

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

5.2

97.7

227

313

N74

ICPC

Malignant neoplasm nervous system

20.9

97.7

N02BF02

ATC

pregabalin; oral

0.3

97.4

386

7763

H3601, E113,

ICD-10 Finland

3.1

97.4

455

1066

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

5.4

97.2

220

296

R06.0

ICD-10 Finland

Dyspnoea

1.4

97.1

7456

42163

JFF10

NOMESCO Finland

Loop enterostomy

4.9

97.0

240

351

H02AB07

ATC

prednisone; oral

1.5

96.8

3578

17773

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

3.1

96.6

453

1064

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.8

96.5

530

1363

NB1BG, ,

SPAT

0.0

96.5

1925

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.0

96.3

460

1092

1BA04, ,

NOMESCO Finland

120.1

96.3

117

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

4.8

96.2

243

362

NK6AN

NOMESCO Finland

Total body bone isotope imaging

2.2

96.1

876

2872

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

16.1

95.8

101

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

9.7

95.8

133

I42.6

ICD-10 Finland

Alcoholic cardiomyopathy

21.5

95.6

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.6

95.6

632

1791

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

0.5

95.5

911

12885

SPAT1172

SPAT

Guidance concerning hydration

2.5

95.4

671

1959

K85

ICPC

Elevated blood pressure

0.6

95.4

2634

27986

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

95.4

1230

4601

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.3

95.3

831

2674

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

95.2

3514

17446

C01DA14

ATC

isosorbide mononitrate; oral

1.5

95.0

4068

20801

ND2AA, ,

SPAT

0.1

94.9

3517

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.6

94.9

596

1646

NF1AA, ,

SPAT

0.1

94.9

3736

B01AC07

ATC

dipyridamole; systemic

2.2

94.7

897

2988

137

Kela drug reimbursment

Uraemia requiring dialysis

4.0

94.5

298

534

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

20.8

94.5

R40.2

ICD-10 Finland

Coma, unspecified

4.3

94.1

276

467

L01XE26

ATC

[U] cabozantinib

24.4

94.0

C09AA02

ATC

enalapril; systemic

1.4

93.9

5479

29622

RS222, ,

NOMESCO Finland

3.5

93.9

355

726

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

31.5

93.8

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.6

93.7

249

388

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

4.3

93.6

274

463

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

0.4

93.4

476

8549

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

3.9

93.4

308

571

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

16.6

93.2

180

Kela drug reimbursment

Interferon alfa

9.0

93.2

136

109

WX110, ,

SPAT

0.3

93.2

321

6911

1502

Kela drug reimbursment

Cabozantinib

8.8

93.1

138

113

V03AE02

ATC

sevelamer; oral

5.2

93.1

218

303

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

0.6

93.0

1989

22396

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

0.4

92.8

398

7718

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

92.8

1528

6188

OAB91, ,

SPAT

0.1

92.8

3803

AAF00

NOMESCO Finland

Ventriculostomy

5.1

92.7

219

307

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.1

92.5

919

3120

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

10.6

92.4

121

H01

ICPC

Ear pain/earache

0.5

92.3

1055

14086

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

15.5

92.2

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

0.4

92.1

585

9596

Z2221

NOMESCO Finland

Medical doctor

1.3

91.1

6997

39499

SPAT1216

SPAT

Assessment of functional ability

1.4

90.9

4422

23144

SPAT1111

SPAT

Planning of analgesia

3.5

90.7

344

705

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

6.6

90.7

168

183

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

5.7

90.6

194

247

WX722

NOMESCO Finland

PEEP

1.9

90.6

1339

5241

PE1AT

NOMESCO Finland

Femoral artery PTA

3.2

90.5

403

917

ZXH06, ,

SPAT

0.3

90.5

233

5845

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.8

89.8

231

350

B01AF01

ATC

rivaroxaban; oral

0.6

89.7

2026

22538

M53.0

ICD-10 Finland

Cervicocranial syndrome

0.5

89.3

714

10746

A10BA02

ATC

metformin; oral

1.3

89.1

8178

47359

N02BE01

ATC

paracetamol; systemic, rectal

0.7

89.0

24107

182803

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

7.2

88.8

153

L01XE10

ATC

[U] everolimus

36.9

88.7

F29

ICPC

Eye symptom/complaint other

0.5

88.6

970

13133

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

88.5

920

3179

L30.9

ICD-10 Finland

Dermatitis, unspecified

0.7

88.4

2958

30272

1CX08, ,

NOMESCO Finland

6.5

88.4

167

186

D69.5

ICD-10 Finland

Secondary thrombocytopenia

7.0

88.2

156

161

3012

Kela drug reimbursment

Cabozantinib

8.4

88.0

134

114

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

88.0

2705

12896

N05AH02

ATC

clozapine; systemic

3.0

87.9

430

1036

N04AA02

ATC

biperiden; systemic

2.7

87.6

524

1411

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.0

87.6

429

1034

M77.1

ICD-10 Finland

Lateral epicondylitis

0.4

87.6

464

8201

K83.0

ICD-10 Finland

Cholangitis

2.9

87.3

441

1082

I80.2

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

14.7

87.3

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

13.2

87.2

101

SPAT1310

SPAT

Counselling related to known health issue

0.7

86.9

5969

54080

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

11.6

86.9

108

Z49.2

ICD-10 Finland

Other dialysis

4.3

86.9

255

432

C34.2

ICD-10 Finland

Malignant neoplasm: Middle lobe, bronchus or lung

354.5

86.7

5CM18, ,

NOMESCO Finland

6.4

86.7

164

183

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

86.6

2029

9063

WX780

NOMESCO Finland

Remote monitoring CPAP

0.3

86.6

215

5505

WX320

NOMESCO Finland

Spinalanesthesy

0.7

86.5

4353

41409

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.2

86.4

372

829

XG466

NOMESCO Finland

Sleep oxymetry

2.1

86.3

896

3094

NG1BG, ,

SPAT

0.0

86.2

2935

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

2.3

86.1

742

2376

A10BJ06

ATC

semaglutide; parenteral

0.3

86.0

304

6468

C71.33

ICD-10 Finland

Malignant tumor of parietal lobe grade IV glioma

32.3

86.0

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.8

86.0

482

1254

N03AX18

ATC

lacosamide; systemic

4.1

85.7

266

471

J01FF01

ATC

clindamycin; systemic

1.3

85.6

7274

41613

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

15.4

85.5

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

3.8

85.3

290

550

N05AB01

ATC

dixyrazine; systemic

3.1

85.3

395

921

L02BA01

ATC

tamoxifen; oral

2.0

85.1

1025

3741

L01XE03

ATC

[U] erlotinib

123.3

85.0

103

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.5

85.0

1086

14036

L02BG06

ATC

exemestane; oral

2.7

85.0

502

1343

G30.0

ICD-10 Finland

Alzheimer disease with early onset

4.4

85.0

240

394

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

10.6

84.9

111

W18

ICD-10 Finland

Other fall on same level

179.7

84.8

100

RD210, ,

NOMESCO Finland

2.9

84.6

440

1098

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.8

84.6

217

328

N03AB02

ATC

phenytoin; systemic

3.4

84.3

330

691

323

Kela drug reimbursment

Sorafenib

16.9

84.2

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

0.7

84.1

3274

32599

AXX01, ,

SPAT

0.2

83.9

133

4456

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

4.1

83.8

258

454

8500/3-C25.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of pancreas, NOS

18.6

83.6

JFB30

NOMESCO Finland

Right hemicolectomy

2.9

83.4

425

1048

G04BD12

ATC

mirabegron; oral

0.6

83.4

1801

20273

H04.10

ICD-10 Finland

Dry eye syndrome

0.6

83.3

1306

15937

OAA62, ,

SPAT

0.0

83.2

2914

J81

ICD-10 Finland

Pulmonary oedema

6.1

83.2

165

194

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.8

83.1

282

534

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

9.6

83.1

116

J96.9

ICD-10 Finland

Respiratory failure, unspecified

4.6

83.0

224

354

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

82.9

1574

6643

NF3AA

NOMESCO Finland

Femur X-ray examination

2.4

82.8

622

1873

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

82.7

1137

4345

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

0.4

82.5

333

6647

C16.3

ICD-10 Finland

Malignant neoplasm: Pyloric antrum

45.9

82.2

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

4.6

82.2

221

348

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

0.6

82.2

1464

17282

JAH01

NOMESCO Finland

Laparoscopy

2.0

82.2

1029

3808

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.6

82.0

540

1527

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

6.1

81.8

162

190

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

4.8

81.8

208

312

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

9.0

81.8

119

G04CA01

ATC

alfuzosin; oral

0.6

81.6

1929

21273

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

12.0

81.5

M16.1

ICD-10 Finland

Other primary coxarthrosis

0.6

81.3

1731

19561

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.0

81.3

1018

3767

L01BC53

ATC

tegafur, combinations; systemic

13.2

81.3

J01CA04

ATC

amoxicillin; systemic

0.8

81.2

19734

153157

N05AA01

ATC

chlorpromazine; systemic, rectal

3.1

81.1

377

881

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

11.5

81.0

101

R12

ICD-10 Finland

Heartburn

0.5

80.9

745

10684

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

5.0

80.7

196

282

SGA02

NOMESCO Finland

Opening and preparing the root canals

0.6

80.7

1531

17793

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

80.6

1865

8301

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

80.4

1141

4405

H61.2

ICD-10 Finland

Impacted cerumen

0.5

80.2

643

9678

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

3.2

80.2

344

765

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

0.5

79.7

872

11827

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.2

79.7

699

2255

WZA90

NOMESCO Finland

Other medical or dental certificate

0.7

79.5

3729

35973

S01GX01

ATC

cromoglicic acid; ophthalmic

0.7

79.1

2474

25722

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.1

79.1

356

816

A10BB07

ATC

glipizide; oral

3.7

79.0

281

551

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

0.4

78.9

359

6784

A07AA09

ATC

vancomycin; oral

2.8

78.6

424

1080

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

322.0

78.6

ZXE90

NOMESCO Finland

More than 22 hours

4.4

78.5

218

353

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.7

78.5

480

1308

NB1AA, ,

SPAT

0.1

78.3

3050

TPX15

NOMESCO Finland

Removal of vascular injection port

4.7

78.3

203

310

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.6

78.2

289

582

R053, ,

ICD-10 Finland

0.0

78.2

1377

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

77.9

2045

9387

B01AC06

ATC

acetylsalicylic acid; oral

2.4

77.9

568

1687

8041/3-C34.3

ICD-O-3

Small cell carcinoma, NOS, of lower lobe, lung

37.7

77.9

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

4.6

77.9

206

320

U02

ICPC

Urinary frequency/urgency

0.6

77.8

1914

20939

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.7

77.6

460

1233

E66.0

ICD-10 Finland

Obesity due to excess calories

3.2

77.3

331

735

D22

ICD-10 Finland

Melanocytic naevi

0.3

77.2

199

4995

WX723

NOMESCO Finland

CPAP therapy

0.3

77.2

207

5083

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

21.0

76.8

ZXE00

NOMESCO Finland

One hour or less

1.3

76.7

10153

61405

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.3

76.7

220

366

J93.8

ICD-10 Finland

Other pneumothorax

5.1

76.6

181

254

Coronary artery bypass surgery

2.6

76.5

472

1292

B37.7

ICD-10 Finland

Candidal sepsis

10.8

76.4

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

0.7

76.4

5600

50466

N17

ICPC

Vertigo/dizziness

0.6

76.3

1658

18666

K72.1

ICD-10 Finland

Chronic hepatic failure

11.3

76.2

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

76.2

2816

13944

WX111

NOMESCO Finland

Local infiltration anesthesia

0.3

76.0

206

5031

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

20.1

75.7

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

12.0

75.6

AA1AA

NOMESCO Finland

Head X-ray examination

3.8

75.5

257

488

R53

ICD-10 Finland

Malaise and fatigue

1.3

75.5

5713

32041

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

3.2

75.5

339

776

L01XE13

ATC

[U] afatinib

30.6

75.4

I21.1

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

8.0

75.1

119

107

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

5.1

75.1

180

256

J01MA02

ATC

ciprofloxacin; systemic

1.3

75.0

10820

66078

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.9

74.8

243

446

OAB93, ,

SPAT

0.2

74.7

3535

A06AC01

ATC

ispaghula (psylla seeds); oral

0.7

74.7

4743

43677

5BA08, ,

NOMESCO Finland

4.8

74.7

191

288

C34.01

ICD-10 Finland

Malignant tumor of the main bronchial epidermoid carcinoma

15.5

74.7

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

0.6

74.6

1293

15392

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

6.8

74.6

134

141

C09AA05

ATC

ramipril; oral

1.3

74.4

7288

42373

XF600, ,

SPAT

0.2

74.3

102

3757

S02.51

ICD-10 Finland

Fracture of tooth, open

0.6

74.2

1077

13447

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

15.7

74.2

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.1

74.1

797

2789

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

74.1

5184

28719

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

11.6

74.1

M54.2

ICD-10 Finland

Cervicalgia

0.5

74.1

695

9914

G04CB02

ATC

dutasteride; oral

0.5

74.0

957

12347

H93.1

ICD-10 Finland

Tinnitus

0.5

73.9

666

9630

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

3.4

73.9

298

637

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

6.7

73.8

135

145

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.1

73.8

343

802

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

3.6

73.7

274

554

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

2.6

73.7

460

1267

8145/3-C16.9

ICD-O-3

Carcinoma, diffuse type of stomach, NOS

13.3

73.6

N05AC02

ATC

thioridazine; oral

2.5

73.6

495

1415

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.7

73.4

1433

6091

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

0.6

73.3

1571

17755

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.1

73.1

224

393

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

12.5

73.0

I71.3

ICD-10 Finland

Abdominal aortic aneurysm, ruptured

6.4

73.0

138

154

X31

ICD-10 Finland

Exposure to excessive natural cold

7.9

72.8

116

105

D63.0

ICD-10 Finland

Anaemia in neoplastic disease

28.2

72.7

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

4.2

72.6

216

370

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

5.2

72.6

168

231

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

0.6

72.6

1190

14379

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.7

72.4

256

500

G03FA14

ATC

dydrogesterone and estrogen; systemic

0.4

72.2

361

6552

I49.3

ICD-10 Finland

Ventricular premature depolarization

0.5

72.2

729

10154

C48.89

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor

15.1

72.0

R95

ICPC

Chron obstructive pulmonary disease

2.0

71.9

829

2978

V03AA01, ,

ATC

2.5

71.8

504

1471

K03.80

ICD-10 Finland

Irradiated enamel

0.3

71.7

248

5338

K05.18

ICD-10 Finland

Chronic gingivitis

0.4

71.7

497

7899

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

2.3

71.6

599

1893

L01EX05

ATC

regorafenib; oral

12.8

71.5

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.7

71.5

419

1117

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

4.9

71.3

177

260

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

71.1

3745

19799

C34.89

ICD-10 Finland

Malignant overall tumor of the bronchus and lung other or unspecified histology

19.8

71.1

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.5

71.1

794

10710

8160/3-C24.9

ICD-O-3

Cholangiocarcinoma of billiary tract, NOS

29.2

71.0

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

2.2

71.0

642

2098

S04

ICPC

Lump/swelling localized

0.6

70.7

1177

14170

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.9

70.3

357

879

G04CA52

ATC

tamsulosin and dutasteride; systemic

0.6

70.3

1530

17237

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

7.6

70.2

115

108

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

0.5

70.2

935

11968

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

10.0

70.2

JFF23

NOMESCO Finland

Transversostomy

2.9

70.1

364

908

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.6

70.1

1226

14571

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.6

70.1

259

522

N81.6

ICD-10 Finland

Rectocele

0.5

70.0

558

8428

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

1.8

70.0

1239

5120

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.4

69.9

550

1692

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

10.3

69.7

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.0

69.7

797

2854

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

0.2

69.6

117

3781

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.7

69.6

4435

40896

H3600, E113,

ICD-10 Finland

2.9

69.6

360

896

G44.2

ICD-10 Finland

Tension-type headache

0.6

69.6

1553

17399

R01BA52

ATC

pseudoephedrine, combinations; oral

0.8

69.5

5292

47569

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.7

69.5

396

1040

C15.4

ICD-10 Finland

Malignant neoplasm: Middle third of oesophagus

9.7

69.5

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

7.0

69.4

122

125

N06DX01

ATC

memantine; oral

1.6

69.3

1685

7585

N05AF05

ATC

zuclopenthixol; systemic

3.3

69.2

289

632

L16

ICPC

Ankle symptom/complaint

0.6

69.1

1315

15303

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

3.2

69.0

303

684

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.8

68.8

1070

4252

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.2

68.8

613

1991

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

5.8

68.7

143

177

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.0

68.7

782

2796

C08DB01

ATC

diltiazem; oral

1.8

68.5

1235

5130

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

2.5

68.5

468

1348

G02BA03

ATC

plastic IUD with progestogen

0.4

68.5

352

6313

G03AC03

ATC

levonorgestrel; oral, implant

0.5

68.5

813

10768

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

3.4

68.4

277

594

WW200

NOMESCO Finland

Immunization

2.1

68.2

708

2445

C16.09

ICD-10 Finland

Malignant tumor of cardiac or other unspecified carcinoma

11.2

68.0

N99

ICPC

Neurological disease other

2.9

68.0

359

904

G30.1

ICD-10 Finland

Alzheimer disease with late onset

1.7

68.0

1299

5486

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.8

68.0

233

445

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

5.6

67.9

146

187

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

4.4

67.9

188

304

GDC00

NOMESCO Finland

Lobectomy of lung

4.3

67.7

198

335

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.1

67.6

701

2420

R999, ,

ICD-10 Finland

+∞

67.5

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.3

67.4

572

1819

SPAT1251

SPAT

Organisation of medication

2.0

67.4

806

2933

196

Kela drug reimbursment

Paricalcitol and cinacalcet

4.7

67.3

175

268

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

67.3

597

1935

C54.2

ICD-10 Finland

Malignant neoplasm: Myometrium

35.9

67.3

H91.1

ICD-10 Finland

Presbycusis

0.5

67.1

678

9448

9440/3-C71.2

ICD-O-3

Glioblastoma, NOS, of temporal lobe

86.1

67.1

DFF15

NOMESCO Finland

Speech audiometry

0.4

67.0

449

7233

N06AX11

ATC

mirtazapine; oral

1.3

66.8

8729

52487

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

4.0

66.7

212

383

C34.91

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma

12.6

66.6

J31.0

ICD-10 Finland

Chronic rhinitis

0.5

66.6

782

10396

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

0.6

66.4

1167

13863

A12AA12

ATC

[U] calcium acetate

8.8

66.4

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.0

66.3

813

2985

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

0.6

66.3

1729

18725

F009, G309,

ICD-10 Finland

17.8

66.3

K30

ICD-10 Finland

Functional dyspepsia

0.6

66.3

1336

15341

M67.4

ICD-10 Finland

Ganglion

0.5

66.3

521

7909

A07AA11

ATC

rifaximin; oral

6.2

66.2

129

149

G56.0

ICD-10 Finland

Carpal tunnel syndrome

0.7

66.1

1857

19799

ZX108

NOMESCO Finland

Inhalation

3.6

66.1

241

481

N05CD08

ATC

midazolam; nasal, systemic

2.2

66.0

613

2025

B05DB

ATC

Hypertonic solutions

3.9

66.0

216

399

JDB00

NOMESCO Finland

Gastrostomy

11.5

65.9

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

5.9

65.9

136

167

C02DE04, ,

ATC

2.4

65.8

497

1501

Z43.0

ICD-10 Finland

Attention to tracheostomy

12.8

65.6

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

10.0

65.6

R09

ICPC

Sinus symptom/complaint

0.5

65.5

575

8400

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.3

65.5

267

575

C07AG02

ATC

carvedilol; oral

1.6

65.5

1579

7092

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

3.9

65.4

217

405

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

5.3

65.2

148

200

B05DA

ATC

Isotonic solutions

3.7

64.9

226

437

F01.9

ICD-10 Finland

Vascular dementia, unspecified

3.3

64.9

264

568

R00.2

ICD-10 Finland

Palpitations

0.5

64.8

670

9271

C71.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of brain

523.1

64.8

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

10.5

64.7

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

64.7

10105

61978

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.0

64.5

758

2741

SAA03

NOMESCO Finland

Extended examination of mouth

0.8

64.5

7100

60995

8140/3-C15.5

ICD-O-3

Adenocarcinoma, NOS, of lower third of esophagus

13.8

64.5

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.8

64.4

9207

76752

K04.08

ICD-10 Finland

Other specified pulpit

0.5

64.0

474

7357

284

Kela drug reimbursment

Nintedanib and pirfenidone

4.4

64.0

181

298

X42

ICD-10 Finland

Accidental poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified

515.9

63.9

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

3.8

63.8

213

399

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

0.5

63.8

650

9038

E85.4

ICD-10 Finland

Organ-limited amyloidosis

18.8

63.7

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

9.5

63.7

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

63.6

1116

4599

K04.1

ICD-10 Finland

Necrosis of pulp

0.6

63.6

1236

14324

N05AB03

ATC

perphenazine; systemic, rectal

1.9

63.5

821

3071

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

3.8

63.4

213

401

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

0.5

63.4

726

9728

L04AA06

ATC

mycophenolic acid; systemic

2.3

63.4

531

1680

C16.23

ICD-10 Finland

Malignant tumor of the corpus ventriculi diffuse carcinoma

10.2

63.4

153

Kela drug reimbursment

Lenalidomid

3.8

63.3

211

395

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

0.7

63.2

3577

33654

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.7

63.2

1195

5032

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.5

63.1

449

1319

168

Kela drug reimbursment

Axitinib

17.7

63.1

2507B

ICD-9 Finland

Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]

9.6

63.1

N01

ICPC

Headache

0.5

63.0

852

10868

SDA05

NOMESCO Finland

Very demanding periodontal treatment

0.5

62.9

541

7961

V03AE03

ATC

lanthanum carbonate; oral

5.1

62.9

148

207

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

11.3

62.9

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

0.6

62.8

922

11493

N03AF02

ATC

oxcarbazepine; oral

2.0

62.7

786

2909

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

62.7

992

3963

HMAK, ,

NOMESCO Finland

0.6

62.5

1290

14738

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

0.6

62.3

1646

17791

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.8

62.3

333

845

F0019, G301,

ICD-10 Finland

14.8

62.1

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

7.8

62.1

100

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

62.0

1248

5346

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.1

61.9

637

2192

C71.3

ICD-10 Finland

Malignant neoplasm: Parietal lobe

174.6

61.9

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

0.6

61.9

958

11774

A11

ICPC

Chest pain NOS

0.6

61.8

1043

12531

212

Kela drug reimbursment

Gout

2.3

61.7

500

1559

B35.1

ICD-10 Finland

Tinea unguium

0.5

61.6

613

8588

9440/3-C71.1

ICD-O-3

Glioblastoma, NOS, of frontal lobe

132.7

61.6

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

9.9

61.5

KA3EB

NOMESCO Finland

Antegrade pyelography

4.1

61.4

189

333

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

61.4

2523

12730

I23.0

ICD-10 Finland

Haemopericardium as current complication following acute myocardial infarction

33.2

61.3

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

12.5

61.2

J02AC03

ATC

voriconazole; systemic

6.6

61.1

113

123

R03AC18

ATC

indacaterol; inhalant

3.6

61.0

227

460

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

6.3

60.9

117

133

280

Kela drug reimbursment

Clopidogrel

2.6

60.9

374

1022

KAC10

NOMESCO Finland

Total nephrectomy with capsule

3.3

60.8

249

538

EBA00

NOMESCO Finland

Extraction of tooth

0.8

60.8

6776

58226

C24.0

ICD-10 Finland

Malignant neoplasm: Extrahepatic bile duct

249.8

60.5

E83.50

ICD-10 Finland

Hypercalcemia

2.6

60.5

397

1122

322

Kela drug reimbursment

Sunitinib

7.2

60.3

103

102

L11

ICPC

Wrist symptom/complaint

0.6

60.2

827

10509

8140/3-C80.9

ICD-O-3

Adenocarcinoma, NOS, of unknown primary site

28.7

60.2

H60.9

ICD-10 Finland

Otitis externa, unspecified

0.5

60.2

656

8929

GAC00

NOMESCO Finland

Biopsy of pleura

5.1

60.0

141

197

A10AA03, ,

ATC

4.2

59.9

177

302

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

3.4

59.9

243

522

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

59.9

659

2327

340

Kela drug reimbursment

Everolimus

16.1

59.8

F16

ICPC

Eyelid symptom/complaint

0.4

59.8

385

6303

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.9

59.7

316

797

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

0.4

59.7

368

6130

H01.0

ICD-10 Finland

Blepharitis

0.5

59.6

478

7209

SGC00

NOMESCO Finland

Medication, disinfection of root canals

0.6

59.1

1110

12984

WX726

NOMESCO Finland

High-flow oxygen therapy

9.5

59.1

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

21.1

59.1

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

4.3

58.8

168

279

9052/3-C38.4

ICD-O-3

Epithelioid mesothelioma, malignant of pleura, NOS

18.9

58.7

F05.8

ICD-10 Finland

Other delirium

3.4

58.7

234

497

DM1QA, ,

SPAT

0.1

58.7

2218

C25

ICD-10 Finland

Malignant neoplasm of pancreas

13.9

58.6

C15.3

ICD-10 Finland

Malignant neoplasm: Upper third of oesophagus

13.9

58.6

D75

ICPC

Malignant neoplasm colon/rectum

3.1

58.4

266

615

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

2.9

58.4

307

772

C80.9

ICD-10 Finland

Malignant neoplasm, primary site unspecified

+∞

58.4

C07AB03

ATC

atenolol; systemic

1.6

58.4

1420

6389

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

3.8

58.3

195

366

AN3

Balloon angioplasty and metallic stent

2.0

58.3

707

2586

M20.1

ICD-10 Finland

Hallux valgus (acquired)

0.6

58.1

961

11614

L02AE03

ATC

goserelin; implant

3.2

58.0

257

584

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.5

58.0

650

8773

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

2.6

57.9

380

1074

D07AD01

ATC

clobetasol; topical

0.7

57.9

2605

25472

J91

ICD-10 Finland

Pleural effusion in conditions classified elsewhere

9.2

57.8

UJF32, ,

SPAT

0.2

57.8

119

3397

I20.00

ICD-10 Finland

Unstable angina

2.0

57.7

722

2670

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

20.8

57.6

C16.03

ICD-10 Finland

Malignant tumor of cardiac diffuse carcinoma

16.6

57.6

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

7.9

57.4

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

2.1

57.3

593

2045

JAL00

NOMESCO Finland

Biopsy of peritoneum

4.0

57.3

178

316

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.7

57.3

342

921

GD2CT

NOMESCO Finland

Cytology of the lungs with CT guidance

9.2

57.3

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

3.0

57.2

277

664

D06BB10

ATC

imiquimod; topical

0.5

57.2

436

6701

RS230, ,

NOMESCO Finland

4.4

57.2

159

258

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

3.8

57.2

194

368

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.2

57.2

519

1699

WX002

NOMESCO Finland

Sedation and analgesia

1.3

57.1

5356

30795

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.8

57.0

926

3728

H92.0

ICD-10 Finland

Otalgia

0.4

57.0

399

6327

ZXD35

NOMESCO Finland

Usual procedure

1.9

57.0

829

3225

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

6.3

56.9

110

126

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

6.9

56.9

101

105

C76.8

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites

31.3

56.8

SAE01, ,

NOMESCO Finland

0.0

56.7

1073

F19.0

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, acute intoxication

84.9

56.7

G31.0

ICD-10 Finland

Circumscribed brain atrophy

4.3

56.5

164

276

N05AD03

ATC

melperone; systemic

3.1

56.5

253

579

WX890

NOMESCO Finland

Intesive care monitoring

3.7

56.5

195

375

M01AX05

ATC

glucosamine; oral

0.7

56.4

3752

34541

OAA64, ,

SPAT

0.1

56.4

2102

L04AX04

ATC

lenalidomide; oral

3.7

56.4

200

392

C02CA01

ATC

prazosin; oral

2.6

56.3

348

954

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

0.6

56.3

782

9912

L01XE23

ATC

[U] dabrafenib

15.1

56.2

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.5

56.2

401

1180

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

0.6

56.2

825

10295

NA1BG, ,

SPAT

0.1

56.2

1241

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

6.0

56.1

112

133

NA3AA, ,

SPAT

0.2

56.0

2845

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

2.6

56.0

358

999

L04AA01

ATC

[U] ciclosporin

2.5

56.0

390

1135

167

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

13.5

55.9

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.8

55.9

299

759

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

4.9

55.9

138

202

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

4.7

55.9

144

219

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

4.1

55.9

170

297

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

4.7

55.9

145

222

N95

ICD-10 Finland

Menopausal and other perimenopausal disorders

0.1

55.8

2382

Z94.0

ICD-10 Finland

Kidney transplant status

2.7

55.8

316

828

R85

ICPC

Malignant neopl respiratory other

9.5

55.6

C09AA01

ATC

captopril; oral

2.5

55.6

392

1147

Z30.2

ICD-10 Finland

Sterilization

0.5

55.5

620

8382

JN6AD

NOMESCO Finland

CT of torso and neck

2.3

55.5

479

1535

R07.4

ICD-10 Finland

Chest pain, unspecified

0.8

55.4

5730

49804

A04AA03

ATC

tropisetron; systemic

5.7

55.3

116

145

J94.9

ICD-10 Finland

Pleural condition, unspecified

3.9

55.3

178

325

A23

ICPC

Risk factor NOS

0.5

55.2

689

9006

A02BC04

ATC

rabeprazole; oral

0.6

55.2

972

11561

K56.0

ICD-10 Finland

Paralytic ileus

3.0

55.1

262

622

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

3.5

55.1

212

440

XPX08

NOMESCO Finland

Intraoperative flow measurement

3.1

54.9

246

563

C18.6

ICD-10 Finland

Malignant neoplasm: Descending colon

23.9

54.9

29599

ICD-8 Finland

Schizophrenia, Unspecified type

3.8

54.9

183

343

PD4CM

NOMESCO Finland

Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet

6.4

54.7

104

117

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

2.7

54.6

325

874

H02AB09

ATC

hydrocortisone; systemic

2.1

54.6

556

1906

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

3.4

54.6

213

446

S83.2

ICD-10 Finland

Tear of meniscus, current

0.5

54.5

710

9168

JMA10

NOMESCO Finland

Transabdominal total splenectomy

3.9

54.5

176

322

HA1AA, ,

SPAT

0.1

54.3

2075

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

0.6

54.3

1007

11823

M77.4

ICD-10 Finland

Metatarsalgia

0.5

54.2

454

6748

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

3.8

54.2

186

356

H40.0

ICD-10 Finland

Glaucoma suspect

0.6

54.2

1012

11865

ACC51

NOMESCO Finland

Release of median nerve

0.6

54.2

795

9926

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

0.5

54.1

424

6450

ZXF00

NOMESCO Finland

Interruption caused by intraoperative deterioration of general condition

4.3

53.9

154

256

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

0.4

53.8

315

5356

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

6.0

53.8

108

129

NH1BG, ,

SPAT

0.0

53.8

1016

C71.80

ICD-10 Finland

Overall malignant tumor of the brain without histology

32.3

53.6

WX721

NOMESCO Finland

Oxygen concentrator therapy

6.2

53.6

105

122

9989/3-C42.1

ICD-O-3

Myelodysplastic syndrome, NOS, of bone marrow

11.4

53.6

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

4.4

53.6

151

248

EB2VA, ,

NOMESCO Finland

0.0

53.6

1071

ZY000

NOMESCO Finland

Hospital inpatient

2.9

53.5

277

691

3009

Kela drug reimbursment

Niraparib

9.7

53.4

H02AA02

ATC

fludrocortisone; oral

3.4

53.3

207

432

AA1

Conventional CABG

2.2

53.2

494

1633

A44

ICPC

General and Unspecified, Preventive immunization/medic

0.6

53.2

898

10799

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

53.1

685

2560

L02BX02

ATC

degarelix; parenteral

2.6

53.1

345

971

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

5.7

53.0

112

141

C71.22

ICD-10 Finland

Malignant tumor of temporal lobe grade III glioma

20.3

53.0

YJ1CD

NOMESCO Finland

Very extensive CT examination of abdomen for dose design of radiotherapy

25.9

52.9

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

2.3

52.8

439

1385

SXC05

NOMESCO Finland

Other oral or dental procedure

0.5

52.7

499

7114

JDH35

NOMESCO Finland

Endoscopic insertion of duodenal stent

21.1

52.7

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

0.4

52.7

350

5662

C15.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of oesophagus

16.4

52.6

343

Kela drug reimbursment

Pazopanib

10.5

52.6

N81.1

ICD-10 Finland

Cystocele

0.5

52.4

660

8607

393

Kela drug reimbursment

Pomalidomide

7.8

52.3

K05.1

ICD-10 Finland

Chronic gingivitis

0.5

52.3

612

8157

N06DA03

ATC

rivastigmine; oral, transdermal

1.7

52.2

963

4026

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

3.9

52.1

168

307

ZXA00

NOMESCO Finland

Right side

1.2

52.1

7190

43251

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

2.5

52.1

356

1027

C34.15

ICD-10 Finland

Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma

11.8

52.0

C15.1

ICD-10 Finland

Malignant neoplasm: Thoracic part of oesophagus

12.9

52.0

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

2.4

52.0

400

1219

L04AX05

ATC

pirfenidone; oral

5.2

51.9

121

168

XCK20, ,

NOMESCO Finland

4.8

51.9

130

193

JN1AE, ,

SPAT

0.2

51.9

2393

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

5.1

51.7

123

174

H04AA01

ATC

glucagon; nasal, parenteral

2.4

51.6

401

1228

WX600

NOMESCO Finland

Single shot through catheter

2.6

51.6

338

955

D07AB02

ATC

hydrocortisone butyrate; topical

0.8

51.5

5258

45850

HAC20

NOMESCO Finland

Total mastectomy

1.7

51.5

1022

4360

R03AC12

ATC

salmeterol; inhalant

1.7

51.4

992

4198

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

4.8

51.3

130

195

DFF00, ,

SPAT

0.0

51.2

1102

YKA02

NOMESCO Finland

Excision of kidneys from cadaver donor

415.1

51.2

FP1B5, ,

SPAT

0.2

51.2

2421

K85

ICD-10 Finland

Acute pancreatitis

2.3

51.1

429

1359

1510

Kela drug reimbursment

Niraparib

9.4

51.0

-1, ,

NOMESCO Finland

0.8

51.0

5599

48423

I81

ICD-10 Finland

Portal vein thrombosis

4.4

51.0

143

234

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

2.7

51.0

297

790

L86

ICPC

Back syndrome with radiating pain

0.5

50.9

613

8103

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.7

50.9

133

205

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

4.9

50.9

127

188

SAA01, ,

SPAT

0.0

50.8

935

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

6.7

50.8

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

2.1

50.7

532

1845

C09CA01

ATC

losartan; oral

0.8

50.7

5350

46487

NH1AA, ,

SPAT

0.1

50.6

1901

GCA32

NOMESCO Finland

Endoscopic insertion of stent into bronch

18.9

50.6

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

4.8

50.6

127

189

AB14W, ,

NOMESCO Finland

9.4

50.5

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.2

50.5

463

1523

SGB20

NOMESCO Finland

Root filling of tooth with onetwo root canals

0.5

50.4

463

6666

XX9XW, ,

NOMESCO Finland

3.3

50.3

207

449

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

4.0

50.3

156

277

N03AE01

ATC

clonazepam; systemic

1.6

50.2

1377

6372

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

0.5

50.2

656

8465

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.5

50.2

390

5952

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

0.5

50.1

384

5891

C03AA03

ATC

hydrochlorothiazide; oral

1.4

50.1

2403

12455

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

50.1

492

1664

N06AA12

ATC

doxepin; systemic

1.6

50.0

1280

5827

115

Kela drug reimbursment

Breast cancer

1.5

50.0

2023

10161

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

4.5

50.0

135

214

C50.3

ICD-10 Finland

Malignant neoplasm: Lower-inner quadrant of breast

7.9

50.0

C34.02

ICD-10 Finland

Malignant tumor of the main bronchial adenocarcinoma

17.4

50.0

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

2.7

50.0

288

762

H91.9

ICD-10 Finland

Hearing loss, unspecified

0.5

49.9

442

6445

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

5.2

49.9

115

158

D07AC01

ATC

betamethasone; topical

0.8

49.9

7314

61298

NB1BA, ,

SPAT

0.1

49.8

1121

R04.2

ICD-10 Finland

Haemoptysis

1.8

49.8

861

3532

C50.99

ICD-10 Finland

Breast, unspecified

1.9

49.7

700

2694

C24.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of biliary tract

26.3

49.7

L01AA01

ATC

cyclophosphamide; systemic

4.9

49.6

122

178

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.1

49.6

233

549

362

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

14.9

49.5

FXG00

NOMESCO Finland

Insertion and use of IABP

6.5

49.5

101

M03BC51

ATC

orphenadrine, combinations; systemic

0.8

49.5

4734

41641

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.6

49.4

1145

5086

JFA65

NOMESCO Finland

Endoscopic insertion of ileum stent

141.1

49.4

Z93.3

ICD-10 Finland

Colostomy status

2.9

49.3

255

636

X73

ICD-10 Finland

Intentional self-harm by rifle, shotgun and larger firearm discharge

+∞

49.2

N083, E102,

ICD-10 Finland

13.2

49.2

L03AB05

ATC

interferon alfa-2b; parenteral

4.5

49.2

135

217

H26.4

ICD-10 Finland

After-cataract

0.7

49.1

1514

15894

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

1.8

49.0

743

2928

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.9

48.9

629

2349

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

3.9

48.9

160

296

PD4BD

NOMESCO Finland

Extensive CT of lower extremity arteries

4.0

48.9

155

280

TK820

NOMESCO Finland

Peritoneal dialysis

4.1

48.9

148

258

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

6.6

48.7

ZXA05

NOMESCO Finland

Left side

1.2

48.7

6652

39913

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

0.3

48.7

160

3536

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

48.7

3750

20942

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

0.4

48.7

273

4725

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

48.5

675

2588

C71.29

ICD-10 Finland

Malignant tumor in temporal lobe other or unspecified histology

24.3

48.5

N06DA02

ATC

donepezil; oral

1.6

48.5

1306

6018

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

5.2

48.5

113

157

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

0.8

48.4

8730

71707

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.1

48.3

496

1706

L04AD01

ATC

ciclosporin; systemic

2.2

48.3

463

1550

F21, ,

ICPC

3.2

48.3

213

483

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.1

48.3

478

1621

D74

ICPC

Malignant neoplasm stomach

9.6

48.2

R06AE09

ATC

levocetirizine; oral

0.7

48.2

1735

17692

F45.8

ICD-10 Finland

Other somatoform disorders

0.5

48.2

364

5615

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

2.5

48.2

321

915

I79.2*E10.5

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

8.3

48.1

Z43.1

ICD-10 Finland

Attention to gastrostomy

8.3

48.1

A10BH01

ATC

sitagliptin; oral

1.4

48.1

2606

13788

G03FA01

ATC

norethisterone and estrogen; systemic

0.7

48.0

1911

19137

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

0.6

48.0

1098

12284

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

4.6

48.0

126

195

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

3.4

48.0

186

388

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

3.4

48.0

186

388

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

3.8

48.0

163

310

NB1AE, ,

SPAT

0.1

48.0

1814

R96

ICPC

Asthma

0.6

47.9

1243

13527

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.3

47.9

397

1251

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.8

47.9

761

3044

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

0.3

47.8

100

2828

R03BA08

ATC

ciclesonide; inhalant

0.6

47.8

977

11219

Z99.8

ICD-10 Finland

Dependence on other enabling machines and devices

18.1

47.8

L89

ICPC

Osteoarthrosis of hip

0.4

47.6

318

5137

WX100

NOMESCO Finland

Conjunctival surface anesthesia

0.7

47.6

2184

21343

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.7

47.5

168

329

C02DE02, ,

ATC

2.7

47.5

281

754

WF099

NOMESCO Finland

Other radiotherapy

3.4

47.4

189

402

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

3.4

47.4

187

395

8000/3-C25.0

ICD-O-3

Neoplasm, malignant of head of pancreas

104.0

47.4

H84

ICPC

Presbyacusis

0.4

47.3

340

5342

F20.0

ICD-10 Finland

Paranoid schizophrenia

3.4

47.3

188

399

GAC01

NOMESCO Finland

Endoscopic biopsy of pleura

5.5

47.3

103

134

R47.1

ICD-10 Finland

Dysarthria and anarthria

2.8

47.2

250

632

L02

ICPC

Back symptom/complaint

0.6

47.2

1074

12028

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

0.5

47.2

443

6334

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

4.3

47.1

136

228

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

0.7

47.1

1959

19467

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

4.2

46.9

139

238

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

3.4

46.9

186

394

R01AD01

ATC

beclometasone; nasal

0.7

46.9

2105

20649

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

4.8

46.8

119

179

L02AB02

ATC

medroxyprogesterone; systemic

3.7

46.8

164

319

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

0.6

46.8

848

10027

K03.66

ICD-10 Finland

Tooth plaque

0.6

46.8

817

9751

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

1.9

46.8

665

2568

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.5

46.7

1445

6869

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.0

46.7

580

2140

OAB47, ,

SPAT

0.1

46.6

2052

ND1AA, ,

SPAT

0.1

46.6

1769

K64.1

ICD-10 Finland

Second degree haemorrhoids

0.2

46.6

2267

C71.83

ICD-10 Finland

Overall malignant tumor of the brain grade IV glioma

102.2

46.5

L02BB03

ATC

bicalutamide; oral

2.0

46.4

581

2150

L01AA03

ATC

melphalan; systemic

8.7

46.4

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

2.5

46.3

312

894

M03BC01

ATC

orphenadrine (citrate); systemic

0.8

46.3

3552

32176

WX610

NOMESCO Finland

Patient controlled analgesia

3.4

46.2

186

398

W19

ICD-10 Finland

Unspecified fall

1.4

46.2

2365

12391

M54

ICD-10 Finland

Dorsalgia

0.7

46.2

1475

15389

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

10.1

46.1

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

1.8

46.1

755

3048

GX1E5, ,

SPAT

0.0

46.0

983

W92

ICD-10 Finland

Exposure to excessive heat of man-made origin

7.2

46.0

L71

ICPC

Malignant neoplasm musculoskeletal

11.2

46.0

H02.3

ICD-10 Finland

Blepharochalasis

0.6

46.0

785

9422

SPAT1058

SPAT

PEF monitoring instruction

0.6

45.9

1054

11785

F38

ICPC

Eye, Other laboratory test NEC

0.1

45.9

1676

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.1

45.8

483

1679

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.0

45.6

567

2093

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

3.8

45.6

151

282

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

2.5

45.4

305

873

JD1EE

NOMESCO Finland

Ultrasound examination of gastro-oesophageal reflux

5.3

45.3

102

137

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

2.6

45.3

283

781

8140/3-C26.9

ICD-O-3

Adenocarcinoma, NOS, of gastrointestinal tract, NOS

48.7

45.3

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

0.6

45.3

755

9121

Single vessel balloon catheter extension

2.0

45.3

496

1749

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

0.7

45.2

1335

14150

C09BA02

ATC

enalapril and diuretics; systemic

1.4

45.2

2146

11095

NH1BA, ,

SPAT

0.1

45.2

1033

M15

ICD-10 Finland

Polyarthrosis

0.5

45.1

514

6910

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

4.8

45.1

113

168

K90

ICPC

Stroke/cerebrovascular accident

1.8

45.0

728

2927

E66.9

ICD-10 Finland

Obesity, unspecified

1.8

44.9

711

2841

X57

ICD-10 Finland

Unspecified privation

2.0

44.8

547

2006

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

2.4

44.8

328

978

X81

ICD-10 Finland

Intentional self-harm by jumping or lying before moving object

28.0

44.8

C53.0

ICD-10 Finland

Malignant neoplasm: Endocervix

28.0

44.8

V03AF03

ATC

calcium folinate; systemic

8.1

44.8

K29.2

ICD-10 Finland

Alcoholic gastritis

4.9

44.6

111

164

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

3.2

44.5

197

448

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

3.2

44.5

194

437

K64.0

ICD-10 Finland

First degree haemorrhoids

0.2

44.5

2379

9050/3-C38.4

ICD-O-3

Mesothelioma, malignant of pleura, NOS

59.5

44.4

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

0.7

44.4

1493

15430

SPA02

NOMESCO Finland

Preparation for dental prosthetics

0.4

44.4

214

3949

M86.6

ICD-10 Finland

Other chronic osteomyelitis

4.2

44.4

132

227

J05AB01

ATC

aciclovir; systemic

0.8

44.4

3545

31963

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

2.7

44.3

263

707

G03FB08

ATC

dydrogesterone and estrogen; systemic

0.5

44.3

436

6141

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

4.0

44.3

138

246

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.9

44.3

621

2388

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

3.5

44.2

166

339

C71.00

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles without histology

13.8

44.2

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

6.8

44.1

A02BC01

ATC

omeprazole; systemic

1.2

44.1

6920

42068

J02AC02

ATC

itraconazole; systemic

0.7

44.1

2757

25708

8010/3-C34.9

ICD-O-3

Carcinoma, NOS, of lung, NOS

126.7

44.1

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

3.1

44.0

205

481

L01EF01

ATC

palbociclib; oral

4.3

44.0

126

210

L01XE31

ATC

[U] nintedanib

6.6

44.0

J93.9

ICD-10 Finland

Pneumothorax, unspecified

3.9

44.0

145

270

M76.6

ICD-10 Finland

Achilles tendinitis

0.5

44.0

434

6106

R07.0

ICD-10 Finland

Pain in throat

0.5

43.8

542

7112

B01AF02

ATC

apixaban; oral

0.7

43.8

2355

22465

H60

ICD-10 Finland

Otitis externa

0.5

43.8

374

5524

P70

ICPC

Dementia

2.1

43.8

477

1679

G41.0

ICD-10 Finland

Grand mal status epilepticus

7.7

43.8

1507

Kela drug reimbursment

Pomalidomide

7.1

43.8

QDA10

NOMESCO Finland

Incision of skin of lower limb

2.9

43.7

227

568

I61.5

ICD-10 Finland

Intracerebral haemorrhage, intraventricular

7.2

43.7

SGA05

NOMESCO Finland

Opening and preparing the root canals, extremely complicated And time consuming

0.5

43.6

433

6082

WF001

NOMESCO Finland

Preoperative radiotherapy

2.5

43.6

286

809

I27.0

ICD-10 Finland

Primary pulmonary hypertension

6.3

43.6

C34.06

ICD-10 Finland

Malignant tumor of the main bronchial microcellular carcinoma

58.4

43.6

N05BA09

ATC

clobazam; oral

3.8

43.5

148

282

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

3.5

43.5

166

343

R5110, ,

SPAT

0.6

43.4

885

10174

C71.9

ICD-10 Finland

Malignant neoplasm: Brain, unspecified

27.2

43.3

SPAT1151

SPAT

Treatment of major wounds

2.3

43.3

337

1034

C08CA05

ATC

nifedipine; systemic

1.5

43.2

1372

6557

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

0.7

43.1

2250

21565

XX7AT

NOMESCO Finland

Radiation therapy with Radium-223

21.0

43.1

5770D

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA NONHAEMORHAGICA]

4.2

43.1

128

220

M65.3

ICD-10 Finland

Trigger finger

0.5

43.0

392

5664

I49.1

ICD-10 Finland

Atrial premature depolarization

0.4

43.0

297

4736

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

0.5

43.0

515

6822

QBG00

NOMESCO Finland

Debridement of bedsore of trunk

8.7

43.0

Z72.1

ICD-10 Finland

Alcohol use

2.4

42.9

319

958

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

0.8

42.9

4184

36818

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

6.0

42.8

103

PDH54

NOMESCO Finland

Bypass from aorta to bilateral femoral arteries

7.0

42.7

SPAT1249

SPAT

Treatment-related counselling outside office

0.8

42.7

8078

66288

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

11957

62132

1.62

321.45

3.8

2.5

65.56

63.41

u/l

0.15

11297

56855

(3035880) pH of Pleural fluid

628

738

6.20

316.25

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

9587

47318

1.65

314.70

3.9

2.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

387

236

11.88

314.18

1.5

1.3

25.54

33.31

g/l

0.70

307

184

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1353

3057

3.27

308.92

1.6

1.4

—

(3010813) Leukocytes [#/volume] in Blood

24040

216023

0.07

307.65

50.9

20.5

7.83

6.61

e9/l

148.90

23135

209657

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

10106

106546

0.52

307.65

2.8

2.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3838

49336

0.49

307.65

2.7

3.1

0.96

0.74

ug/l

8.04

2688

33944

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1171

2268

3.80

307.65

2.7

2.6

2562.64

14.70

u/ml

1.95

1155

2240

(3023368) Bacteria identified in Blood by Culture

15925

50295

3.63

307.65

6.8

3.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3688

11819

2.40

307.65

5.7

3.1

5.23

5.11

kpa

9.33

3502

11185

(3023183) Ammonium ion [Moles/volume] in Plasma

2609

2892

6.96

307.65

3.3

2.4

40.15

29.73

umol/l

44.37

2379

2589

(3003396) Base excess in Arterial blood by calculation

7194

21919

2.76

307.65

10.2

6.7

1.33

0.97

mmol/l

7.47

5824

17790

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3682

12697

2.22

307.65

13.5

8.3

0.67

0.66

3651

12640

(3044640) Blood type and Crossmatch panel - Blood

12345

61165

1.74

307.65

4.1

2.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2187

4818

3.42

307.65

1.4

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

9085

30591

2.60

307.65

2.3

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1365

2665

3.79

307.65

1.9

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

18117

169626

0.43

307.65

44.2

16.3

15.44

15.29

3.66

17819

166937

(3020564) Creatinine [Moles/volume] in Serum or Plasma

23387

210476

0.14

307.65

41.9

16.4

89.43

78.81

umol/l

113.71

23374

210435

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

18237

200834

0.14

307.65

3.7

4.9

4.33

4.60

mmol/l

188.94

15828

185434

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

18930

204819

0.12

307.65

4.0

5.5

2.48

2.70

mmol/l

172.37

16301

188411

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2513

6305

3.02

307.65

2.6

2.7

—

(40768806) Pleura Pathology biopsy report

1255

1328

7.01

307.65

1.5

—

(3045788) Cell count panel - Pleural fluid

1114

1187

6.93

307.65

1.5

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3554

11183

2.44

307.65

5.6

3.1

2.33

1.59

mmol/l

17.28

2739

8351

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5895

17574

2.73

307.65

2.6

2.2

0.18

0.22

g/l

263.67

5347

16479

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1862

3679

3.79

307.65

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3578

11753

2.33

307.65

9.8

6.7

24.82

mmol/l

0.00

3535

11666

(3020779) Urea [Moles/volume] in Serum or Plasma

6361

16323

3.26

307.65

9.2

6.9

11.88

9.05

mmol/l

118.86

6052

15560

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2509

6463

2.94

307.65

2.8

2.2

1117.98

373.53

ug/l

4.78

2369

6124

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5669

17227

2.66

307.65

5.5

3.6

5.84

5.80

kpa

1.62

5459

16856

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6033

67537

0.55

307.65

3.9

4.5

21.89

21.96

0.12

2831

34218

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1365

2665

3.79

307.65

1.9

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

19324

197951

0.19

307.65

4.4

5.1

6.41

6.02

mmol/l

148.56

16769

180195

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1308

2343

4.13

307.65

7.5

5.9

12.00

11.48

mg/l

3.25

1195

2162

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2839

8795

2.44

307.65

1.8

1.6

1.69

1.54

g/l

9.41

2416

7553

(3013707) Erythrocyte sedimentation rate by Westergren method

16900

149460

0.58

307.65

4.5

4.2

23.33

11.86

mm/h

307.65

15352

137729

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

18836

181772

0.33

307.65

4.5

4.8

2.17

2.14

mu/l

0.22

16700

165070

(4035726) Immunohistochemistry procedure

5920

16371

2.97

307.65

1.5

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6480

20998

2.53

307.65

2.2

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3230

8450

2.94

307.65

5.6

4.0

24.04

24.19

mmol/l

1.32

3135

8326

(3042936) Bacteria identified in Isolate by Culture

7526

26721

2.35

307.65

2.6

1.9

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

19618

102784

2.01

307.65

14.9

5.3

15.00

11.14

umol/l

66.62

18998

97474

(3012544) pH of Venous blood

5779

18046

2.59

307.65

5.4

3.6

7.36

7.38

1.56

157

(3033658) Prothrombin time (PT) actual/Normal

10307

50254

1.70

307.65

7.3

3.6

81.13

89.77

199.57

10093

49143

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

1564

1814

6.45

307.65

2.0

1.9

38.36

14.25

ug/l

17.18

1533

1781

(3000963) Hemoglobin [Mass/volume] in Blood

24045

216063

0.07

307.65

51.2

20.6

121.71

137.12

g/l

307.65

23487

213343

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1952

3981

3.68

307.65

1.8

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

23360

210546

0.14

307.65

20.8

10.5

30.16

26.12

u/l

22.97

22551

202777

(1761868) Lipid panel - Serum or Plasma

3722

67254

0.31

307.65

2.9

3.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

4389

14330

2.39

307.65

4.7

2.9

4.69

4.57

kpa

2.36

4182

13987

(3033799) Differential panel - Peritoneal fluid

563

296

13.85

307.65

2.1

1.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3623

12137

2.29

307.65

11.1

6.5

24.72

24.62

mmol/l

0.56

3435

11586

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1889

3872

3.66

307.65

1.9

1.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

3717

12815

2.22

307.65

13.6

8.3

92.74

94.32

35.42

3697

12781

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3653

10046

2.82

307.65

11.9

8.8

24.32

24.34

mmol/l

0.08

3508

9804

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

2015

3630

4.18

307.65

4.3

2.9

2409.05

46.45

u/ml

6.53

1848

3290

(3022948) Iron [Moles/volume] in Serum or Plasma

6969

30841

1.80

307.65

3.2

2.5

10.30

13.32

umol/l

208.21

6539

28696

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

15397

149507

0.47

307.65

3.9

4.0

15.09

14.95

pmol/l

7.96

13682

134478

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

590

305

14.10

307.65

2.0

1.8

13133.43

8143.91

e6/l

0.61

330

150

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6939

22242

2.59

307.65

5.5

4.1

298.02

229.35

u/l

65.93

6621

21018

(3024731) MCV [Entitic volume]

24040

216021

0.07

307.65

50.7

20.5

91.95

91.37

51.56

23472

213275

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7194

21956

2.76

307.65

10.2

6.8

5.13

5.09

kpa

2.36

6831

21077

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5466

18945

2.30

307.65

12.0

7.3

115.38

122.90

g/l

112.90

5320

18449

(3027945) Reticulocytes/100 erythrocytes in Blood

5624

22641

1.95

307.65

3.1

2.4

2.04

1.71

63.10

5040

20045

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

3296

5546

4.65

307.65

3.6

2.9

0.34

0.36

u/ml

1.64

1962

3115

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6405

21157

2.47

307.65

2.1

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3951

9823

3.16

307.65

1.8

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

1338

2812

3.52

307.65

3.9

3.1

1.94

1.35

6.00

1220

2470

(3019060) Gas panel - Arterial blood

4413

12268

2.84

307.65

6.8

4.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8118

83967

0.58

307.65

4.9

5.2

8.94

2.26

ug/l

15.70

6925

76106

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

7377

19721

3.21

307.65

5.0

4.0

81.53

3.79

ug/l

20.32

6563

15757

(3028308) Erythrocytes [#/volume] in Pleural fluid

1343

1356

7.37

307.65

1.5

1.4

42955.55

68859.84

e6/l

1.70

841

755

(3003434) Protein [Mass/volume] in Pleural fluid

1580

1730

6.84

307.65

1.5

1.4

33.08

33.99

g/l

1.40

1419

1569

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5528

21244

2.05

307.65

3.9

2.6

19.91

6.62

umol/l

82.78

4941

18553

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

18326

102018

1.71

307.65

12.8

6.1

1.20

1.22

mmol/l

159.40

15673

86526

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7872

24265

2.78

307.65

7.6

5.6

1.08

1.01

mmol/l

56.08

7441

22555

(3019550) Sodium [Moles/volume] in Serum or Plasma

23886

206379

0.23

307.65

41.9

16.0

138.19

139.83

mmol/l

307.65

23257

201947

(3023487) Leukocytes [#/volume] in Peritoneal fluid

669

344

14.21

307.65

2.1

1.9

3071.91

5296.93

e6/l

0.32

475

218

(3002032) Base excess in Venous blood by calculation

5654

17184

2.66

307.65

5.6

3.6

2.13

1.82

mmol/l

5.38

4701

14978

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1540

3439

3.32

307.65

5.6

5.9

1509.37

1108.79

iu/ml

0.19

274

533

(3009542) Hematocrit [Volume Fraction] of Blood

24036

215790

0.07

307.65

51.9

20.6

36.51

40.70

307.65

21885

201486

(3024561) Albumin [Mass/volume] in Serum or Plasma

17556

86230

2.07

307.65

8.9

4.3

30.73

36.12

g/l

307.65

16665

79818

(3000991) Gas panel - Venous blood

5177

16022

2.58

307.65

11.7

7.8

—

(3016502) Oxygen saturation in Arterial blood

6191

20127

2.51

307.65

11.0

7.0

94.41

96.14

61.85

5943

19463

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1493

2918

3.80

307.65

1.9

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2058

4821

3.20

307.65

3.0

2.5

3.77

3.57

g/l

5.19

1979

4615

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6396

26950

1.88

307.65

3.2

2.5

20.40

22.92

28.03

5524

22832

(3012441) Differential panel - Pleural fluid

1249

1324

7.00

307.65

1.5

—

(3007461) Platelets [#/volume] in Blood

24036

215916

0.07

307.65

50.9

20.5

249.42

244.73

e9/l

13.55

23243

210289

(3023103) Potassium [Moles/volume] in Serum or Plasma

23900

206880

0.22

307.65

42.0

16.1

4.00

3.98

mmol/l

15.23

23228

202152

(3014111) Lactate [Moles/volume] in Serum or Plasma

5252

16968

2.47

307.65

10.0

6.5

1.69

1.25

mmol/l

64.84

5111

16588

(3022217) INR in Platelet poor plasma by Coagulation assay

18709

96706

1.98

307.65

17.8

15.7

1.32

1.28

inr

2.85

4912

28014

(3026692) Albumin [Mass/volume] in Peritoneal fluid

426

277

11.15

307.65

1.5

1.4

12.87

13.93

g/l

0.90

335

207

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

17947

199296

0.15

307.65

3.7

4.8

1.34

1.45

mmol/l

188.55

15492

182802

(3009343) pH of Capillary blood

3644

11643

2.41

307.65

5.7

3.1

7.42

0.86

469

1623

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

3063

6313

3.75

307.65

4.4

3.2

6215.98

94.08

u/ml

2.34

2712

5365

(3012095) Magnesium [Moles/volume] in Serum or Plasma

10652

29727

3.39

307.65

5.3

3.0

0.80

0.82

mmol/l

45.64

10191

27622

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

17860

192216

0.20

307.65

3.6

4.3

1.40

1.31

mmol/l

36.70

15406

174553

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8090

30327

2.23

307.65

2.9

1.9

30.40

29.76

11.28

7859

29480

(3003338) MCHC [Mass/volume]

17972

160507

0.52

307.65

46.7

18.1

328.58

332.78

g/l

307.65

17650

159905

(3026361) Erythrocytes [#/volume] in Blood

24038

216032

0.07

307.65

50.9

20.5

4.09

4.53

e12/l

307.65

23132

209676

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

19721

191278

0.27

307.65

34.9

13.1

76.27

77.69

ml/min/173m2

12.26

17251

158199

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

17238

92688

1.75

307.65

11.5

5.5

1.19

1.21

mmol/l

202.19

16343

83666

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

23574

194935

0.42

307.65

38.1

13.2

38.33

23.05

mg/l

307.65

22307

153693

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

18098

190687

0.22

307.65

6.4

6.3

43.38

40.09

mmol/mol

208.01

16041

175804

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1644

3327

3.68

307.65

1.5

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4837

12680

3.05

307.65

1.9

1.5

—

(3044889) 12 lead EKG panel

16010

146583

0.54

307.65

4.7

4.1

—

(3035941) MCH [Entitic mass]

24038

215991

0.07

307.65

50.6

20.4

30.25

30.46

39.91

23463

213262

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1644

3327

3.68

307.65

1.5

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3670

12761

2.20

307.65

13.4

8.2

1.47

1.33

12.47

3635

12696

(3027801) Oxygen [Partial pressure] in Arterial blood

7191

21941

2.76

307.65

10.2

6.7

11.55

12.64

kpa

48.07

6815

21059

(3023199) Leukocytes [#/volume] in Pleural fluid

1458

1511

7.20

307.65

1.5

1.4

3058.18

3275.29

e6/l

0.10

1093

1050

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2125

60969

0.19

307.65

1.5

1.7

1.53

1.36

mmol/l

8.07

1902

50129

(3044007) Cell count panel - Peritoneal fluid

510

281

13.19

307.65

2.0

1.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

6810

25243

2.20

307.65

11.3

6.4

103.26

104.60

mmol/l

67.31

6797

25235

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

788

1006

5.73

307.65

1.3

12.57

13.86

u/l

0.69

727

935

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6613

28608

1.83

307.65

3.1

2.4

2.09

2.35

g/l

187.36

6155

26429

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2067

5352

2.89

307.65

1.9

1.7

—

(3036782) Glucose [Moles/volume] in Pleural fluid

1006

1247

5.94

307.65

1.4

1.3

6.36

6.39

mmol/l

0.11

945

1139

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

3631

6735

4.24

307.65

2.4

1.8

3.20

1.84

ug/l

2.29

3302

5916

(40761511) CBC panel - Blood by Automated count

22874

202284

0.26

307.65

32.1

13.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

1014

1247

5.99

307.65

1.3

587.00

418.18

u/l

1.09

971

1184

(3020630) Protein [Mass/volume] in Serum or Plasma

4295

16790

1.97

307.41

3.3

2.5

63.68

67.10

g/l

110.40

3951

15210

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1127

2264

3.66

306.68

1.7

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

794

1218

4.76

304.24

1.7

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1218

2619

3.43

300.02

2.7

2.8

15065.55

1061.59

u/ml

1.23

108

133

(3007853) Bacteria identified in Skin by Aerobe culture

5255

22128

1.84

299.89

2.3

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

349

14032

0.17

299.12

1.5

1.8

—

(3018418) pH of Serum or Plasma

11587

60522

1.59

298.44

7.0

3.8

7.40

1.82

2332

11377

(3022313) Gas panel - Capillary blood

2605

8474

2.31

297.93

6.3

3.2

—

(40768441) Liver Pathology biopsy report

721

1039

5.06

296.04

1.2

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1087

2224

3.59

287.97

1.2

1.1

—

(3026782) Osmolality of Urine

8208

39781

1.65

283.01

3.5

2.9

521.38

546.83

mosm/kgh2o

23.04

7311

33808

(1616796) Gas panel - Central venous blood

1543

3971

2.88

282.86

5.0

3.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4367

17646

1.90

281.51

3.4

2.4

42.36

49.63

u/l

0.58

3835

14971

(3018405) Lactate [Moles/volume] in Arterial blood

2170

6699

2.42

278.16

6.3

3.8

1.68

1.27

mmol/l

23.72

2115

6605

(21494755) Public health laboratory ask at order entry panel

336

13181

0.17

276.87

1.1

1.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

18865

111382

1.55

272.86

19.6

8.1

4.85

4.03

e9/l

195.32

17130

96106

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

829

1454

4.17

270.33

1.2

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

205

50.94

268.62

1.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

12437

67348

1.54

263.67

7.6

2.9

2.33

2.36

mmol/l

98.12

11349

58144

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3065

11211

2.06

260.84

14.6

8.7

—

(4281824) Cell count and differential, peritoneal fluid

867

1633

3.88

257.52

1.3

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1155

2656

3.20

255.82

1.6

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

678

1057

4.67

254.84

1.4

13.07

12.51

u/l

0.90

652

1026

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7641

37171

1.63

254.71

6.1

2.7

2.50

2.45

mmol/l

183.69

6861

32636

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

931

1865

3.65

253.94

1.8

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3217

12109

2.01

252.82

2.1

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

908

1795

3.70

252.32

1.7

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

908

1796

3.70

252.13

1.7

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

8973

0.06

249.81

1.2

1.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1480

3988

2.74

248.85

4.1

2.9

7.71

8.29

kpa

26.06

1441

3907

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

897

1783

3.68

247.32

1.9

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1056

2345

3.30

247.09

1.6

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1754

5182

2.51

245.93

3.1

2.2

84.54

91.47

22.07

1723

4940

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

851

1650

3.77

242.89

1.9

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3919

16016

1.86

241.01

2.9

2.2

417.65

362.25

nmol/l

31.96

3661

14725

(3026008) Bacteria identified in Urine by Culture

11204

60140

1.52

240.73

3.8

3.2

—

(3003181) Sodium [Moles/volume] in Urine

1289

3324

2.85

234.75

1.4

1.3

59.51

63.19

mmol/l

2.03

953

2701

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1065

2461

3.17

233.83

1.6

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2331

31492

0.49

228.72

1.2

1.3

23.35

13.50

u/ml

2.75

692

11471

(3020891) Body temperature

2270

7757

2.18

228.68

7.9

4.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2281

7832

2.17

227.03

2.5

1.8

—

(3027315) Oxygen [Partial pressure] in Blood

1484

4198

2.61

226.83

6.5

3.3

8.31

8.65

kpa

9.48

1444

4113

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1601

4711

2.51

225.94

3.1

2.4

239.63

188.29

66.65

1524

4450

(3010421) pH of Blood

1632

4849

2.49

225.71

6.6

3.2

7.42

0.21

1444

4471

(3013290) Carbon dioxide [Partial pressure] in Blood

1473

4168

2.61

224.99

6.5

3.3

5.08

4.96

kpa

4.88

1434

4083

(3012501) Base excess in Blood by calculation

1472

4167

2.61

224.64

6.5

3.3

3.22

2.30

mmol/l

21.26

1114

2810

(3027273) Bicarbonate [Moles/volume] in Venous blood

2584

9418

2.05

220.23

5.3

3.0

25.07

25.33

mmol/l

2.33

2500

9158

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2284

7947

2.14

219.65

7.8

3.0

193.71

29.34

u/ml

18.74

2223

7627

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1440

22869

0.42

219.46

1.3

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2618

33432

0.52

213.57

1.2

1.3

54.22

39.87

iu/ml

2.50

847

10542

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1561

4700

2.45

209.62

4.0

2.7

25.04

24.70

mmol/l

1.64

1511

4612

(3012516) Albumin [Mass/volume] in Urine

7043

69473

0.64

208.65

3.2

3.3

726.21

361.55

mg/l

6.69

4915

43943

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2157

7485

2.14

208.47

7.0

3.3

25.15

24.81

mmol/l

4.28

2019

6905

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2101

7220

2.16

208.07

2.2

1.7

—

(3022096) Basophils/100 leukocytes in Blood

15037

87524

1.45

204.04

7.9

6.0

0.54

0.70

211.99

14323

81129

(3017143) Hepatitis C virus Ab [Presence] in Serum

3918

16789

1.77

203.82

1.7

1.6

—

(3043409) Potassium [Moles/volume] in Arterial blood

1793

5818

2.28

203.74

7.0

4.1

3.94

3.87

mmol/l

5.65

1770

5787

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

743

1485

3.65

203.06

1.9

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

743

1485

3.65

203.06

1.9

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

743

1485

3.65

203.06

1.9

1.6

—

(40758558) Short blood count panel - Blood

9201

48715

1.50

201.80

16.1

5.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

867

1935

3.27

200.95

4.6

3.4

—

(3023520) Reticulocytes [#/volume] in Blood

4058

17661

1.74

199.75

3.3

2.5

74.27

68.21

e9/l

11.74

3136

13386

(3004119) Hemoglobin [Mass/volume] in Venous blood

3042

12138

1.88

199.00

5.1

3.0

118.37

131.41

g/l

153.38

2964

11844

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1326

20943

0.43

197.45

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

7364

71357

0.66

196.66

3.2

3.3

6.67

7.56

mmol/l

56.81

5941

59784

(3021901) Oxygen saturation in Capillary blood

1219

3351

2.67

196.62

3.5

2.6

—

(3019069) Monocytes/100 leukocytes in Blood

15452

90797

1.44

196.01

8.2

6.3

8.88

8.80

1.62

14731

84465

(3020682) Albumin/Creatinine [Ratio] in Urine

7569

72834

0.66

194.66

3.7

3.9

28.77

6.62

mg/mmol

71.65

5047

45624

(3036489) Thrombin time

1919

6560

2.17

192.09

2.8

2.0

22.38

21.68

3.74

1801

5725

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

9112

48546

1.49

191.60

2.5

2.3

3.68

2.85

mg/l

113.90

7931

41303

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

388

469

5.99

190.18

1.4

59.44

63.94

1.25

317

395

(3006504) Eosinophils/100 leukocytes in Blood

15329

90312

1.43

188.61

7.9

6.0

2.23

2.99

281.53

14595

83890

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2440

9227

1.97

186.52

4.4

2.5

1.38

1.20

12.47

2429

9184

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

480

733

4.75

184.62

3.9

2.9

—

(3035637) Corticotropin [Mass/volume] in Plasma

863

2027

3.11

184.15

1.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

12726

72945

1.42

178.71

4.1

3.3

—

0.43

—

(3019309) Folate [Moles/volume] in Red Blood Cells

7361

37978

1.51

178.32

1.9

1.7

1203.21

1149.63

nmol/l

4.40

5787

28144

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1439

4501

2.35

177.27

1.7

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3960

17682

1.69

175.92

3.9

2.6

370.02

147.83

ng/l

71.51

3662

16199

(3002030) Lymphocytes/100 leukocytes in Blood

15581

92807

1.41

174.38

8.1

6.1

20.99

28.15

307.65

14849

86562

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10926

61314

1.43

169.91

5.5

3.0

56.04

31.99

u/l

19.64

10398

57850

(3013826) Glucose [Moles/volume] in Serum or Plasma

19236

119148

1.42

169.81

9.2

4.4

7.27

6.73

mmol/l

152.40

18547

112036

(3023383) Lactate [Moles/volume] in Pleural fluid

346

418

5.98

169.69

1.3

3.62

3.28

mmol/l

0.83

323

380

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2349

9060

1.93

168.90

4.4

2.5

0.67

0.64

4.86

2340

9029

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3979

18021

1.67

166.86

1.7

1.5

—

(3042631) Mycobacterium sp identified in Specimen

966

2581

2.73

164.18

2.4

2.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2284

8834

1.92

162.64

5.8

3.6

50.84

47.25

9.11

2254

8744

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

294

313

6.78

161.60

1.4

24.31

22.37

0.40

249

270

(3002582) Erythrocytes [#/volume] in Urine

10939

61887

1.41

159.71

4.0

3.3

114.65

88.56

e6/l

0.69

8885

46984

(3028271) Lactate [Moles/volume] in Capillary blood

1049

2995

2.56

156.61

2.3

1.7

1.88

1.68

mmol/l

5.52

1006

2938

(40760892) CBC W Ordered Manual Differential panel - Blood

15207

91197

1.38

155.93

8.7

6.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

983

2723

2.64

155.83

6.5

2.9

119.31

20.72

u/ml

15.57

956

2645

(40767503) Oxygen content in Capillary blood by calculation

1307

4152

2.31

155.13

3.2

2.4

14.65

16.76

47.37

643

2257

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2004

25459

0.53

154.60

1.3

1.4

—

(3047181) Lactate [Moles/volume] in Blood

1747

6263

2.06

153.79

9.2

5.3

1.59

1.24

mmol/l

18.32

1534

5559

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3707

39930

0.62

152.39

1.2

1.3

2.08

1.75

u/ml

0.56

809

10111

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

544

1073

3.68

151.37

1.9

1.6

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

324

413

5.67

150.90

1.4

2.60

3.27

0.55

272

351

(3037121) Protein [Mass/volume] in Urine

1815

6657

2.01

150.08

4.2

2.9

0.34

0.31

g/l

0.71

1235

2576

(3005719) IgG [Mass/volume] in Serum or Plasma

3145

13756

1.71

148.98

3.0

2.8

10.58

10.55

g/l

0.12

2856

12597

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9252

83009

0.71

147.86

2.3

72.85

79.37

nmol/l

72.47

8163

73572

(3017354) Segmented neutrophils/100 leukocytes in Blood

753

1863

2.94

146.97

3.9

3.1

61.91

55.71

9.79

655

1544

(3051651) Icteric interference index of Serum or Plasma

503

961

3.79

146.29

5.2

3.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3878

18025

1.62

145.22

2.7

2.3

8.63

7.50

ug/l

1.23

3318

15950

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1086

3296

2.41

142.54

1.5

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

614

1368

3.26

142.51

1.7

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

850

2287

2.71

142.43

4.2

5.1

344.05

365.92

umol/l

4.00

732

1969

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

112

42.35

141.98

1.1

1.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1074

3276

2.40

139.40

1.5

1.4

21.22

18.36

u/ml

0.26

(3024928) Oxygen saturation in Venous blood

1240

4054

2.24

137.40

4.1

3.2

—

(3006315) Basophils [#/volume] in Blood

15895

97121

1.36

137.09

7.4

5.8

0.04

e9/l

31.32

13851

82890

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

464

883

3.80

135.68

2.1

1.8

—

(3001604) Monocytes [#/volume] in Blood

15841

96878

1.35

134.83

7.4

5.8

0.67

0.60

e9/l

62.89

13799

82748

(3000919) Neutrophils/100 leukocytes in Pleural fluid

295

384

5.54

134.59

1.3

1.4

23.61

20.63

0.79

261

354

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

463

885

3.79

134.57

2.1

1.8

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

809

2196

2.68

133.25

3.0

3.5

19.28

4.00

nmol/l

1.53

789

2144

(3023419) Bacteria identified in Sputum by Culture

979

2927

2.44

132.62

2.3

2.5

—

(3018010) Neutrophils/100 leukocytes in Blood

15086

91721

1.35

132.41

7.6

5.9

63.35

56.69

307.65

14378

85444

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

294

388

5.47

132.29

1.3

495.89

49.40

ug/l

3.19

184

179

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

684

1701

2.92

132.27

3.3

2.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7453

40493

1.42

130.75

4.8

3.7

622.94

466.61

ng/l

0.66

6566

32876

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1192

3932

2.22

129.19

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2549

10951

1.73

127.76

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

11521

98501

0.74

127.60

6.3

5.0

0.00

estimate

0.11

2553

18158

(3022806) Fractional oxyhemoglobin in Capillary blood

842

2386

2.57

127.43

2.3

1.7

88.06

90.20

13.60

822

2359

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

629

11389

0.38

127.05

1.2

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

1563

5762

1.99

126.92

4.7

3.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

391

688

4.11

126.81

2.3

2.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2506

10741

1.73

126.60

2.0

1.9

1.31

1.32

g/l

0.07

2234

9769

(3013115) Eosinophils [#/volume] in Blood

16226

100118

1.34

126.48

8.0

6.0

0.17

0.20

e9/l

58.62

14210

86769

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

970

2953

2.40

126.33

1.5

131.26

111.35

u/ml

1.34

188

670

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

388

681

4.12

126.25

2.3

2.0

—

(3019198) Lymphocytes [#/volume] in Blood

16104

99286

1.34

125.98

7.6

5.8

1.61

1.95

e9/l

46.77

14232

86744

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

387

681

4.11

125.51

2.3

2.0

—

(3000850) Epithelial cells [#/volume] in Urine

7790

42921

1.40

125.08

3.2

2.6

6.47

4.68

e6/l

22.39

7168

38264

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

669

1709

2.84

123.32

5.7

3.3

136.39

28.01

u/ml

13.05

660

1690

(3014891) Appearance of Pleural fluid

164

114

10.35

123.27

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1141

3775

2.21

122.70

1.3

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

11562

98464

0.74

122.44

4.8

3.7

0.00

estimate

0.31

2728

19318

(3009261) Glucose [Presence] in Urine by Test strip

11732

99567

0.75

120.39

4.8

3.8

0.00

estimate

0.69

2495

17577

(3001019) Free T4 and TSH panel - Serum or Plasma

205

6524

0.22

119.71

1.5

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

353

605

4.21

118.38

1.4

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1017

3261

2.27

117.76

2.0

1.5

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

145

11.58

116.57

2.6

1.9

55.91

64.63

1.06

(3030467) Casts [#/volume] in Urine by Automated count

9951

57549

1.35

116.55

3.9

3.2

0.82

0.36

e6/l

36.27

8075

43378

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

500

1116

3.24

115.72

1.7

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

1850

22307

0.57

115.51

1.9

2.2

285.40

139.01

ug/g

12.19

1493

17444

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

14988

92118

1.32

115.21

4.2

2.4

—

(1002224) Polysomnography panel

280

7229

0.27

114.95

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

548

1314

3.02

112.81

1.3

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

501

1162

3.12

109.01

1.6

1.3

—

(36304419) Bacteria [Presence] in Urine

9552

55332

1.34

108.72

3.9

3.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1121

3869

2.11

108.35

3.0

3.1

0.92

0.76

nmol/l

15.04

843

3028

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2043

8651

1.74

107.03

8.2

4.4

1.79

1.63

7.02

1888

8155

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

446

984

3.28

105.13

1.7

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

489

1146

3.09

104.61

1.6

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

444

990

3.24

102.94

1.8

1.4

—

(3045414) Leukocytes [Presence] in Urine

585

9996

0.41

102.27

2.3

1.9

—

(44786800) Granulocytes/100 leukocytes in Body fluid

155

137

8.14

98.98

1.3

25.87

24.62

0.12

127

(3008536) Aspergillus sp Ab [Presence] in Serum

230

318

5.21

98.73

2.3

2.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2581

27714

0.64

98.53

3.7

5.0

32.13

32.53

0.90

1746

18599

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

228

6056

0.26

98.14

1.9

1.7

9.61

3.67

mg/l

4.05

209

4455

(3008295) Osmolality of Serum or Plasma

644

1823

2.56

97.60

1.3

1.4

278.58

277.39

mosm/kgh2o

0.47

500

1419

(3007930) Methemoglobin/Hemoglobin.total in Blood

1981

8538

1.71

97.13

8.5

4.5

0.92

0.88

1.20

1830

8048

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

117

12.18

96.80

2.7

1.9

15.82

17.73

0.14

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4050

20695

1.46

94.95

5.7

3.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

385

830

3.35

94.09

2.4

2.1

87.88

99.04

5.59

378

778

(3039000) Anion gap in Blood

1216

4569

1.94

93.04

11.1

6.0

11.55

11.08

mmol/l

3.99

1090

4140

(3018572) Chloride [Moles/volume] in Blood

1216

4570

1.94

92.98

11.1

6.0

104.36

105.26

mmol/l

6.18

1091

4141

(40760888) Immunoglobulin light chains.free panel - Serum

1294

4967

1.90

92.95

4.3

3.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

1269

4858

1.91

91.87

1.2

129.92

130.43

titre

0.01

122

400

(4094501) Cardiovascular stress test using bicycle ergometer

285

6412

0.31

90.19

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

4096

21182

1.44

89.72

1.7

1.6

—

(3037756) Immunofixation for Serum or Plasma

1167

4387

1.94

89.12

1.8

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1221

4669

1.91

88.66

1.2

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

3403

17025

1.48

88.29

4.6

4.0

1.21

0.85

17.11

2380

4956

(3045142) Bone marrow Pathology biopsy report

715

2230

2.33

88.10

1.5

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

15520

124309

0.79

86.89

4.8

3.0

115.84

47.35

u/l

258.60

14352

114437

(3039443) Prostate specific Ag panel - Serum or Plasma

139

4617

0.21

86.49

1.5

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1032

13601

0.53

86.27

1.2

—

(3022145) Colonoscopy Study observation

2300

24635

0.64

85.53

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

584

1685

2.51

85.14

1.6

1.5

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

148

150

7.09

84.93

1.4

1.3

71.59

71.07

0.05

126

127

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

155

166

6.71

84.91

1.3

1.2

306.43

255.50

u/l

0.07

120

113

(3034770) Mitochondria Ab [Titer] in Serum

1239

4846

1.87

83.93

1.2

546.00

961.61

titre

2.03

155

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10482

63191

1.28

83.12

4.1

2.8

3183.37

929.89

ng/l

142.93

9486

54293

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

279

6074

0.32

82.64

1.6

1.7

46.51

42.54

nmol/l

1.60

262

5881

(3004588) Protein electrophoresis panel - Serum or Plasma

2961

14653

1.49

80.59

2.9

2.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

130

120

7.78

80.39

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10536

63751

1.28

80.36

2.7

2.1

288.73

203.07

u/l

6.93

9972

59490

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

294

588

3.60

80.34

1.6

1.8

73624.06

5610.19

u/ml

1.21

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

631

9558

0.46

80.11

1.6

1.7

—

(3014271) Vancomycin [Susceptibility]

383

913

3.03

79.71

3.2

2.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1556

6619

1.72

79.59

4.1

3.2

14.06

2.58

ratio

1.11

539

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

204

309

4.75

79.36

1.3

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1256

5022

1.82

79.29

3.9

3.2

1.95

1.54

mg/l

33.40

1167

4552

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5940

33306

1.34

79.13

3.5

3.0

2.91

2.31

e6/l

2.25

3452

17912

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

613

1873

2.37

79.09

3.4

3.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

434

1117

2.81

78.97

1.2

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

374

887

3.04

78.51

1.7

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

400

988

2.92

78.33

2.4

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

373

887

3.03

77.95

1.7

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

167

215

5.59

77.19

1.3

1.2

0.87

2.09

mmol/l

1.36

125

120

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

802

2777

2.10

76.71

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

555

8661

0.45

76.34

1.6

1.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12656

78638

1.26

76.05

5.2

3.5

82.05

61.94

ng/l

0.89

10747

56765

(3034860) Kappa light chains.free [Mass/volume] in Serum

1580

6843

1.69

75.60

4.3

3.3

152.73

44.37

mg/l

1.58

1266

5571

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

137

146

6.74

75.40

2.8

3.4

1.26

1.09

mg/l

0.38

107

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

130

131

7.13

74.99

1.1

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1575

6837

1.68

74.71

4.3

3.3

71.70

37.59

mg/l

3.20

1253

5576

(36660697) Celiac disease serology panel - Serum

1232

14796

0.58

73.48

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

859

3136

1.99

71.22

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

770

2702

2.07

71.11

1.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

931

3513

1.93

70.19

3.9

3.2

4.72

4.00

e9/l

10.77

926

3508

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1395

5965

1.71

69.87

1.4

212.27

275.93

ug/g

25.27

870

3546

(3041918) Cholesterol [Moles/volume] in Pleural fluid

183

284

4.63

69.31

1.3

1.2

1.57

1.85

mmol/l

1.69

143

139

(3019977) pH of Arterial blood

385

998

2.78

69.20

3.1

2.5

7.43

7.42

1.05

139

369

(3022493) Free Hemoglobin [Mass/volume] in Plasma

316

731

3.12

69.19

7.4

4.3

73.67

2081.73

mg/l

2.07

245

519

(3024471) HLA-A [Type]

274

579

3.41

69.14

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

155

208

5.36

68.75

1.4

1.3

13.21

11.07

0.37

100

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

144

180

5.75

68.56

3.1

3.8

42.19

39.89

umol/l

0.47

117

157

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1150

4681

1.79

68.36

2.7

2.1

119.85

131.88

g/l

38.78

827

3374

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

8857

74455

0.79

67.89

5.3

4.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3006

15407

1.44

67.66

4.7

3.8

125.87

86.29

ng/l

37.68

2621

13173

(3011412) CD3 cells [#/volume] in Blood

541

1678

2.33

67.53

2.2

2.4

1.15

1.14

e9/l

0.01

493

1532

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

514

7871

0.46

66.97

1.1

2.35

7.66

u/ml

0.74

110

(3008898) HLA-B27 [Presence]

237

5035

0.33

66.68

1.1

—

(3016038) Potassium [Moles/volume] in Urine

441

1251

2.55

66.62

1.2

34.25

34.76

mmol/l

0.17

383

1066

(3018095) Leukocytes [#/volume] in Urine

11538

71681

1.24

66.27

4.7

3.7

133.51

96.39

e6/l

2.94

9087

50704

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

250

516

3.49

65.36

1.3

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

626

2102

2.16

64.75

9.6

8.7

7.74

7.36

mmol/l

1.39

524

1725

(3052592) Norovirus Ag [Presence] in Stool

174

275

4.55

64.55

1.5

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

640

8972

0.50

64.47

1.0

1.1

—

(3015736) pH of Urine

9484

78759

0.80

63.92

4.4

3.5

5.85

5.80

0.35

235

4703

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1152

13595

0.59

63.75

2.3

2.4

21.83

25.70

au/ml

0.47

924

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

307

736

3.01

63.38

2.7

2.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

792

2942

1.95

62.49

1.2

1.3

299.50

277.31

u/ml

1.25

549

1817

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1019

12349

0.58

62.46

1.2

1.3

58.50

55.59

au/ml

0.13

699

(3041096) Erythrocytes [Presence] in Urine by Automated

5809

50991

0.77

62.37

4.8

3.4

—

(3024932) HLA-DR beta [Type]

261

572

3.29

62.34

1.1

—

(21494434) Karyotype in Bone marrow

538

1726

2.25

62.16

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

176

294

4.30

61.14

1.4

1.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

468

1426

2.37

60.82

1.7

1.4

1.22

1.37

promille

1.14

369

1093

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

229

4720

0.34

60.50

1.4

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

169

278

4.37

59.82

1.7

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

638

2232

2.07

59.41

2.6

2.5

1.52

1.18

g/24h

1.93

351

1060

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

150

224

4.81

59.41

1.9

2.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

475

1479

2.32

58.82

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

483

1518

2.30

58.56

2.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1568

16891

0.65

58.18

2.1

2.2

8.74

13.19

nmol/l

71.68

1314

15088

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

10900

88632

0.81

58.08

2.1

2.0

87.34

96.27

pmol/l

71.65

6348

45241

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1822

8717

1.53

57.42

1.4

1.6

14.34

16.60

u/ml

0.25

217

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

193

368

3.77

56.53

2.5

2.4

—

(40762365) Oxygen content in Arterial blood by calculation

169

292

4.16

56.34

3.7

2.7

14.29

15.03

ml/dl

2.42

156

274

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

216

4407

0.35

55.85

1.7

1.9

175.42

199.44

pmol/l

3.38

198

4152

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

162

273

4.27

55.71

1.3

—

(3045424) Erythrocytes [Presence] in Urine

171

3890

0.31

55.09

1.6

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

282

705

2.88

54.21

2.2

1.7

141.48

116.97

umol/l

0.43

130

375

(3025468) Yersinia sp identified in Specimen by Organism specific culture

662

2447

1.96

53.00

1.7

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

660

2451

1.95

52.14

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

661

2456

1.95

52.14

1.7

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

666

2486

1.94

51.84

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

664

2481

1.94

51.53

1.7

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

677

2547

1.92

51.49

1.7

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

319

879

2.61

51.18

2.2

1.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

395

1207

2.36

51.08

1.9

2.1

—

(3017569) Oxygen content in Arterial blood

318

876

2.62

51.05

2.4

2.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

216

478

3.25

50.91

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

144

238

4.35

50.76

12.3

10.6

5.15

5.45

mmol/l

0.52

144

238

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

653

2440

1.94

50.68

1.1

1.74

1.49

g/l

26.32

581

2219

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1037

4465

1.69

50.48

1.5

1.3

743.99

546.79

mg/l

3.21

983

4249

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1223

5502

1.62

50.20

1.3

1.5

15.37

13.22

iu/ml

0.19

129

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

998

4262

1.70

50.07

1.6

1.3

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

163

301

3.89

49.91

2.6

2.7

1213.30

1746.82

u/l

0.32

144

267

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

347

1010

2.48

49.84

2.6

2.8

35.82

38.08

1.31

212

553

(3044290) Cell count panel - Cerebral spinal fluid

880

3639

1.75

49.51

1.6

1.4

—

(40768804) Tissue Pathology biopsy report

10112

82005

0.83

49.38

2.4

2.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

404

1270

2.29

49.03

2.4

2.6

662.07

641.03

e6/l

0.06

387

1216

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

326

933

2.52

48.50

1.6

—

(3035285) Chloride [Moles/volume] in Venous blood

633

2403

1.90

46.90

3.6

2.0

104.25

105.82

mmol/l

9.93

627

2386

(3041354) Potassium [Moles/volume] in Venous blood

633

2403

1.90

46.90

3.6

2.0

4.10

4.04

mmol/l

2.06

627

2387

(3032057) Clostridioides difficile [Presence] in Stool

170

341

3.58

46.48

2.0

1.6

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

6.85

46.45

1.2

1.3

914.86

1466.48

u/l

0.22

(3000093) Morphology [Interpretation] in Blood Narrative

529

1893

2.02

46.42

1.2

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1034

4548

1.65

46.40

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

428

1416

2.18

46.03

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

3004

16374

1.35

45.83

4.7

4.0

0.15

0.10

4.61

2017

4314

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

917

3920

1.70

45.83

1.4

1.3

3.91

3.81

mmol/l

1.45

850

3703

(3051611) Lipemic interference index of Serum or Plasma

573

2122

1.95

45.67

5.0

3.0

—

(1175426) CD3 cells/100 lymphocytes in Blood

402

1307

2.22

45.12

1.8

2.1

72.42

71.18

0.69

375

1255

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

396

1282

2.23

44.90

1.7

2.1

15.14

16.40

1.25

374

1252

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

909

3910

1.68

44.40

1.7

1.4

5464.62

1775.12

e6/l

0.46

761

3172

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

908

3906

1.68

44.34

1.7

1.4

45.38

30.68

e6/l

0.66

733

2997

(3032352) Blasts [#/volume] in Cerebral spinal fluid

111

165

4.83

44.30

2.4

2.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

103

143

5.17

44.25

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1292

6065

1.55

44.20

3.0

2.2

0.07

0.02

g/l

1.75

1149

5587

(3010375) cycloSPORINE [Mass/volume] in Blood

292

831

2.53

44.00

30.5

29.8

118.41

114.62

ug/l

0.45

252

701

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

365

1156

2.28

43.59

2.5

596.58

514.14

e6/l

0.37

309

986

(3011544) Albumin [Mass/volume] in Pleural fluid

132

5.33

43.45

1.1

1.2

17.31

18.23

g/l

0.40

117

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

310

914

2.44

43.40

1.2

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

615

2374

1.87

43.34

3.7

2.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1570

7714

1.48

43.30

3.1

2.2

10.50

10.06

g/l

2.29

1391

6782

(3010503) CD19 cells [#/volume] in Blood

358

1133

2.28

42.84

2.3

2.6

0.13

0.46

e9/l

2.20

348

1096

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1212

5650

1.56

42.75

3.1

2.3

0.00

g/l

0.86

1070

5190

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

447

1551

2.08

42.64

2.3

1.8

5.48

3.54

mg/l

8.21

419

1489

(3048929) Epstein Barr virus Ab [Presence] in Serum

958

4225

1.64

42.54

1.3

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

313

936

2.41

42.52

1.2

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

486

1742

2.01

42.49

1.3

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1398

6742

1.51

42.21

1.6

184.91

271.24

titre

0.82

287

(3002179) Metamyelocytes/100 leukocytes in Blood

2868

15726

1.34

41.84

4.6

3.8

0.93

0.60

10.52

1957

4390

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6839

41730

1.22

41.65

2.4

1.7

2.62

1.12

mg/l

67.79

5776

32038

(21494890) Protein electrophoresis panel - 24 hour Urine

583

2242

1.88

41.58

2.4

2.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1191

5566

1.55

41.54

3.1

2.3

0.00

g/l

-0.00

1064

5175

(3005322) IgE [Units/volume] in Serum or Plasma

993

10997

0.63

41.33

1.3

438.39

247.58

u/ml

1.08

893

10133

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

348

1113

2.25

40.66

2.5

0.18

0.25

e9/l

5.63

304

986

(3036180) Methadone [Presence] in Urine

198

478

2.98

40.59

2.0

2.1

—

(3000012) Reticulocyte production index

728

3031

1.74

40.03

2.7

2.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

396

1344

2.12

40.03

1.4

1.3

2.62

2.11

mmol/l

6.05

365

1253

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

308

941

2.36

39.96

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

308

941

2.36

39.96

1.4

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

409

1407

2.10

39.93

1.2

124.21

189.65

titre

1.07

258

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1641

8265

1.45

39.79

3.1

2.2

3.78

3.71

g/l

0.59

1474

7390

(3028433) Virus identified in Specimen by Culture

227

599

2.73

39.70

1.2

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

408

1406

2.09

39.66

1.2

224.38

104.67

titre

0.55

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1641

8285

1.44

39.27

3.1

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1642

8293

1.44

39.22

3.1

2.2

7.72

7.37

g/l

10.61

1474

7411

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

231

3907

0.42

38.93

1.6

1.8

—

(40768795) Lymph node Pathology biopsy report

509

1913

1.92

38.92

1.3

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

268

784

2.46

38.22

13.6

17.1

1541.95

1399.51

nmol/l

1.49

247

757

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

389

5417

0.51

38.16

2.0

1.7

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

785

3393

1.67

37.68

1.5

1.4

491.33

120.76

pmol/l

14.91

756

3323

(3020961) Endomysium IgA Ab [Titer] in Serum

667

7936

0.59

37.61

1.1

178.07

215.18

titre

0.27

198

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

150

4.64

37.10

1.1

19.63

19.83

u/l

0.03

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1544

7793

1.44

36.98

3.1

2.2

3.27

2.88

g/l

34.28

1378

6916

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1416

7044

1.46

36.60

3.3

2.4

1.26

0.84

g/l

2.42

1199

6009

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

110

2538

0.31

36.52

1.1

0.67

1.50

u/ml

2.73

1282

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

167

3145

0.38

36.33

1.7

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1708

0.17

36.32

1.2

1.3

88.42

174.92

pmol/l

4.86

1708

(3042733) HLA Ab [Presence] in Serum

222

609

2.62

36.10

3.9

5.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

275

837

2.36

36.04

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

280

864

2.33

35.59

1.3

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

189

480

2.83

35.52

1.2

1.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

19227

129367

1.17

35.42

5.8

4.5

1470.84

1280.37

e6/l

0.19

362

1752

(40765096) Chromosome analysis panel by Banding

203

539

2.71

35.16

1.2

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

420

1531

1.98

35.13

1.7

2.2

36.73

37.35

0.32

411

1504

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

8.92

34.97

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.40

34.92

1.1

1.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

802

3565

1.63

34.55

4.6

2.7

60.45

65.52

7.21

797

3549

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

145

320

3.25

34.50

1.4

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1300

6443

1.46

34.23

3.0

2.1

34.55

38.22

g/l

70.85

1133

5548

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

215

597

2.59

34.17

1.4

1.2

—

(40768443) Skin Pathology biopsy report

916

9916

0.65

34.13

1.3

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

2185

0.29

33.27

1.0

1.1

0.36

1.05

u/ml

3.21

905

(3003888) Timothy IgE Ab [Units/volume] in Serum

2257

0.30

33.09

1.0

1.1

2.79

3.80

u/ml

0.32

1098

(40758292) HTLV I+II Ab panel - Serum

125

260

3.45

32.57

1.4

1.5

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

120

4.84

32.55

1.2

1.1

9.07

7.88

mg/l

0.41

112

(40768800) Prostate Pathology biopsy report

439

5612

0.55

32.40

1.1

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

264

831

2.29

32.13

2.5

2.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

246

753

2.35

31.90

8.9

12.2

881.29

835.29

nmol/l

0.64

230

725

(3028707) Methadone [Presence] in Urine by Screen method

403

1503

1.93

31.62

3.7

2.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

214

3429

0.44

31.45

1.3

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

852

3934

1.57

31.35

1.2

109.09

141.73

titre

0.32

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1962

0.28

30.85

1.0

1.1

0.70

1.22

u/ml

0.66

974

(3014051) Protein [Presence] in Urine by Test strip

467

5781

0.57

30.66

3.1

2.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

6328

51805

0.84

29.88

1.7

1.5

18.01

20.78

nmol/l

42.79

5757

43358

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1033

10645

0.68

29.87

1.2

132.18

136.47

iu/ml

0.11

268

3871

(3008037) Lactate [Moles/volume] in Venous blood

945

4514

1.51

29.83

4.9

2.9

1.90

1.53

mmol/l

12.69

922

4416

(3013512) EKG study

7982

64077

0.85

29.56

5.0

4.0

—

(3006576) Bicarbonate [Moles/volume] in Blood

222

672

2.37

29.55

7.4

6.2

25.13

25.20

mmol/l

0.06

199

599

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

312

1088

2.06

29.54

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

312

1091

2.06

29.33

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

476

1929

1.78

28.84

1.7

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5920

36719

1.19

28.57

3.3

2.8

2.01

1.07

e6/l

1.33

3410

21172

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

193

557

2.49

28.46

3.7

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

193

557

2.49

28.46

3.7

2.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

208

623

2.40

28.36

1.4

340685.71

2035256.84

iu/ml

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

304

1067

2.05

28.32

1.1

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1656

0.25

28.07

1.0

3.92

3.06

u/ml

0.11

765

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.52

27.69

1.9

2.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

693

3168

1.58

26.67

1.3

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

179

517

2.49

26.40

1.7

2.2

83.58

29.78

u/l

2.32

158

470

(3006922) Hepatitis E virus Ab [Presence] in Serum

322

1186

1.95

26.29

1.1

—

(3047189) Immunofixation for 24 hour Urine

276

962

2.06

26.24

2.0

1.7

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

104

222

3.36

26.17

9.0

8.2

0.55

0.34

umol/l

0.48

202

(3003327) Ova and parasites identified in Stool by Light microscopy

533

6125

0.62

26.01

1.7

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

191

573

2.39

26.00

2.0

35.24

28.47

5.17

169

543

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

197

601

2.36

25.85

1.5

2.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

160

444

2.59

25.60

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

18187

137073

0.88

25.38

5.7

4.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

158

438

2.59

25.34

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

100

214

3.35

25.09

1.0

1.5

—

43.22

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1551

0.28

24.78

1.0

1.71

3.54

u/ml

1.32

615

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

322

1215

1.91

24.54

1.4

14.87

13.01

umol/l

3.53

299

1152

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1355

0.23

24.52

1.0

0.21

0.42

u/ml

—

410

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

193

3.46

24.44

1.2

1.1

—

(3004451) EKG impression Narrative

289

1053

1.97

24.38

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

156

441

2.54

24.09

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

499

2161

1.66

23.93

1.3

1.2

77.61

58.45

u/l

3.22

467

1900

(3006245) CD3-CD19+ cells/100 cells in Blood

186

573

2.33

23.93

2.0

2.1

11.05

11.02

0.01

150

534

(3048879) Bone marrow aspiration report

188

594

2.27

22.86

2.0

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1258

0.23

22.75

1.2

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

865

4300

1.45

22.47

5.2

2.9

8.28

7.44

mmol/l

10.76

848

4214

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

119

303

2.82

22.47

1.1

6.35

2.73

pmol/l

1.07

(3002256) Pathology report gross observation

3245

27598

0.82

22.46

1.4

1.3

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

9.66

22.43

1.1

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

153

445

2.47

22.33

1.1

—

(3019225) pH of Specimen

3519

21244

1.21

22.23

7.6

3.9

—

(3023410) Appearance of Cerebral spinal fluid

412

1733

1.71

22.06

1.9

1.5

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

7.59

22.00

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

143

411

2.50

21.41

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

214

734

2.09

21.33

1.5

2.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1021

5282

1.40

21.29

1.3

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2911

17316

1.22

21.28

7.6

3.4

1.22

1.23

mmol/l

20.25

2738

14915

(3025941) Bacteria identified in Stool by Culture

1762

9891

1.29

21.26

1.4

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1023

5297

1.40

21.22

1.3

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

109

274

2.85

21.09

1.3

1.2

139.09

117.30

ng/l

0.21

180

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

315

1241

1.83

21.09

1.7

1.5

8.81

6.99

u/l

0.95

266

981

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1011

5234

1.40

20.99

1.3

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.39

20.65

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

157

481

2.34

20.53

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

328

1320

1.79

20.50

1.1

296.73

285.37

mg/l

1.45

284

1191

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

254

943

1.94

20.40

2.3

2.4

2991.45

831.93

u/ml

6.84

248

932

(3011397) Hemoglobin [Presence] in Urine by Test strip

5964

47872

0.87

20.29

4.3

3.7

—

(3017732) Neutrophils [#/volume] in Blood

1512

13790

0.77

19.59

4.3

2.9

5.95

5.07

e9/l

1.19

1165

10624

(3017704) Immunofixation for Urine

290

1141

1.83

19.54

1.7

1.6

—

(3000492) Spirometry study

2110

18492

0.80

19.43

1.7

1.5

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

251

945

1.91

19.38

1.2

1.1

3.84

4.12

iu/ml

0.13

(3000060) B lymphocytes [#/volume] in Blood

133

392

2.43

18.96

1.9

2.1

799.84

1466.47

e6/l

0.34

215

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

152

2278

0.48

18.78

1.1

1.2

8.07

7.62

mmol/l

1.05

138

1931

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

107

3.95

18.78

1.1

1.0

—

(3019150) Specific gravity of Urine by Refractometry

5303

42703

0.87

18.59

5.2

4.2

1.02

kg/l

0.51

916

6311

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

170

567

2.15

18.27

3.1

3.0

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

140

3.48

18.19

1.3

0.92

1.08

ml/s/173m2

0.56

(3008116) Ketones [Moles/volume] in Urine by Test strip

124

362

2.46

18.06

1.6

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

115

326

2.53

17.80

2.7

1.6

7.43

2.20

ug/l

0.78

181

(3018851) Theophylline [Moles/volume] in Serum or Plasma

146

3.34

17.12

1.8

1.7

44.56

45.52

umol/l

0.09

146

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1156

0.31

16.97

1.2

1.3

1.51

1.54

g/l

0.33

1156

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

248

973

1.83

16.94

3.4

3.8

—

(3020393) Adenovirus Ag [Presence] in Stool

167

3.13

16.66

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

243

955

1.83

16.53

1.4

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.20

16.51

4.4

3.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

4.60

16.49

1.2

0.06

0.08

g/l

2.08

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

812

0.19

16.47

1.3

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

201

743

1.94

16.47

2.4

2.3

59.95

52.58

umol/l

1.83

163

628

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

340

1479

1.65

16.21

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

193

2.94

16.18

1.1

—

(3021589) Normoblasts [#/volume] in Blood

11619

88646

0.90

16.09

17.3

9.5

0.01

0.00

e9/l

2.42

9298

72957

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

216

830

1.87

15.79

1.5

1.2

51.27

64.52

1.64

(3026250) Tacrolimus [Mass/volume] in Blood

215

827

1.87

15.67

32.4

34.4

7.28

7.25

ug/l

0.05

186

746

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

197

2.88

15.63

1.1

—

(3025130) Human papilloma virus identified in Specimen

1618

0.44

15.59

1.7

1.6

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

181

658

1.97

15.58

1.8

2.2

204.72

153.36

8.07

162

621

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

319

1380

1.66

15.56

1.4

1.3

29.10

33.44

u/l

1.51

284

1103

(3025159) Blasts/100 leukocytes in Blood

2595

15736

1.20

15.38

4.7

4.0

0.60

0.20

2.10

1611

3746

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

273

2.55

15.31

1.4

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

116

357

2.33

15.16

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

727

3772

1.39

15.01

1.4

13.83

9.86

u/l

8.46

572

3040

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

118

368

2.30

14.98

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

176

643

1.96

14.96

1.7

1.6

1.70

2.08

umol/l

6.62

165

606

(44813793) Dust mix specific IgE antibody measurement

1259

0.38

14.83

1.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

459

2197

1.50

14.58

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

119

3.37

14.39

1.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

288

1242

1.67

14.27

1.4

1.2

134.05

81.45

u/l

7.81

265

1064

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

141

484

2.09

14.22

1.9

2.3

252.39

175.64

7.81

134

460

(4212803) Bone marrow aspirate examination

169

2.93

14.13

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

984

5403

1.31

14.05

1.4

1.6

0.24

g/l

0.07

911

5118

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

280

1205

1.67

13.99

1.4

1.2

48.15

19.59

u/l

7.17

250

1012

(3026493) Urate [Moles/volume] in Serum or Plasma

7200

56045

0.90

13.98

4.2

2.6

3348.25

5099.43

umol/l

3.08

6212

48612

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

390

0.13

13.83

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

837

0.27

13.76

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3334

27232

0.86

13.76

14.2

6.5

—

(3022689) Creatine [Moles/volume] in Urine

695

0.21

13.76

2.0

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

642

3317

1.39

13.64

1.5

1.3

76.65

29.65

u/l

7.22

557

2875

(3007164) IgA [Mass/volume] in Serum or Plasma

4282

34340

0.88

13.58

1.8

1.5

3.15

2.51

g/l

24.79

2878

19501

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

403

1909

1.52

13.49

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

186

2.78

13.44

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

141

495

2.04

13.43

2.9

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

732

0.23

13.43

1.2

1.5

—

(3013862) HLA-DP [Type]

4.56

13.34

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

721

6898

0.74

13.31

1.7

1.6

—

(3045716) Anion gap in Serum or Plasma

229

948

1.73

13.21

3.0

2.3

9.86

9.72

mmol/l

0.19

220

927

(43055442) Apixaban [Mass/volume] in Serum or Plasma

273

2.42

13.09

1.7

1.4

131.25

110.80

ug/l

0.87

217

(40763590) HLA-DQ beta [Type]

4.60

13.09

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

159

2082

0.54

13.04

1.0

1.1

6.12

3.86

u/ml

0.85

812

(40761535) Cells panel - Urine sediment

2770

17129

1.17

13.01

4.3

3.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

562

2865

1.41

12.93

2.5

2.1

31.79

32.89

5.85

552

2847

(46236302) HLA-C [Type] by High resolution typing

4.51

12.82

1.0

—

(40760410) HLA-B [Type] by High resolution

4.51

12.82

1.0

—

(40760409) HLA-A [Type] by High resolution

4.51

12.82

1.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1000

5583

1.29

12.66

1.5

1.6

1.14

1.19

g/l

5.14

938

5306

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

303

2.30

12.36

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

622

0.21

12.33

1.2

1.5

—

(3000330) Specific gravity of Urine by Test strip

1237

10937

0.80

12.27

5.4

3.4

—

(3029937) Albumin [Presence] in Urine by Test strip

6848

53145

0.90

12.24

5.2

4.2

0.00

estimate

0.74

2216

17582

(4200892) Spirometry reversibility

1852

15716

0.83

12.15

1.4

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

120

413

2.08

12.10

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

619

3248

1.37

12.04

1.3

1.5

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

127

452

2.02

11.73

1.2

1.1

89.04

108.39

5.54

119

412

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

106

3.25

11.70

2.8

5.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

760

0.30

11.62

1.0

1.1

1.40

1.78

u/ml

—

260

(3024980) IgG subclass 4 [Mass/volume] in Serum

581

3037

1.38

11.58

1.3

1.6

0.79

0.83

g/l

0.22

438

2246

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

677

0.26

11.52

1.1

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

676

0.26

11.49

1.1

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

675

0.26

11.47

1.1

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

580

0.21

11.46

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

238

1037

1.65

11.45

7.3

11.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

674

0.26

11.44

1.1

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

539

5258

0.73

11.38

1.3

1.2

35.74

39.91

u/ml

0.15

291

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.62

11.25

1.0

1.2

—

mmol/l

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.85

11.21

1.7

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

3.68

11.13

13.7

10.1

142.97

324.71

e6/l

0.63

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.42

11.10

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

145

2.82

11.02

1.2

1.1

24.61

11.24

iu/ml

0.74

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.45

10.46

1.0

—

(3022621) pH of Urine by Test strip

1583

13441

0.83

10.44

3.7

2.9

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

303

2.18

10.43

1.2

66.02

77.83

1.90

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

167

678

1.77

10.42

2.8

2.9

29.64

28.60

umol/l

0.50

125

508

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

103

3.13

10.41

1.2

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

738

0.33

10.41

1.0

1.1

0.60

4.40

u/ml

—

188

(3026470) Cobalt [Mass/volume] in Blood

129

1676

0.55

10.41

1.5

2.0

4.75

3.52

ug/l

0.46

111

1547

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

304

2.17

10.35

1.2

72.77

87.13

2.35

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

150

591

1.82

10.33

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

240

1078

1.60

10.28

1.1

—

(4062490) Immunoglobulin typing, IgG

379

1879

1.45

10.26

1.2

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

264

2.25

10.23

1.1

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

211

919

1.65

10.23

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

108

3.05

10.22

1.1

1.16

1.06

u/field

0.46

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

164

2.62

10.19

1.5

2.4

0.95

1.08

mmol/l

0.17

111

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

1082

0.45

10.18

1.0

1.1

6.56

10.27

iu/ml

1.94

238

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

217

954

1.63

10.15

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

237

1065

1.60

10.14

1.2

303.16

350.41

u/l

0.33

221

982

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

471

4592

0.73

9.96

1.1

23.84

7.93

u/ml

0.82

447

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

120

445

1.93

9.96

1.2

1.1

72.54

88.98

4.25

212

(3028192) IgG subclass 2 [Mass/volume] in Serum

378

1886

1.44

9.92

1.2

1.4

2.65

2.99

g/l

2.25

266

1277

(3027135) IgG subclass 1 [Mass/volume] in Serum

378

1886

1.44

9.92

1.2

1.4

7.37

6.72

g/l

1.43

265

1277

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.44

9.91

1.5

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

248

1134

1.57

9.88

1.1

399.93

307.17

mg/l

1.20

217

997

(3043238) Trisomy 21 risk [Likelihood] in Fetus

584

0.27

9.87

1.1

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

121

452

1.92

9.84

1.2

1.1

75.36

87.22

2.89

210

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

493

4763

0.74

9.83

1.3

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

318

1538

1.49

9.79

1.9

2.0

2.05

2.34

u/field

0.41

144

625

(3024139) IgG subclass 3 [Mass/volume] in Serum

377

1885

1.44

9.79

1.2

1.4

0.47

0.41

g/l

1.28

264

1281

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

597

3223

1.33

9.74

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

104

3.03

9.69

1.3

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

4.43

9.66

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

257

1192

1.55

9.63

1.2

1.1

60.15

44.83

mg/l

1.40

217

1000

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

310

2.10

9.53

1.3

1.2

111.39

110.23

0.08

297

(3015076) Soybean IgE Ab [Units/volume] in Serum

628

0.31

9.52

1.0

0.73

0.96

u/ml

—

186

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1387

11817

0.83

9.52

2.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

141

561

1.80

9.46

2.8

2.4

158.75

150.22

nmol/l

0.27

118

486

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

231

1052

1.58

9.39

1.2

1.1

134.04

76.48

u/l

6.19

214

937

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

448

0.19

9.37

1.2

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

564

0.28

9.31

1.1

1.4

—

(3025577) Chromium [Mass/volume] in Blood

129

1620

0.57

9.28

1.6

2.1

2.62

2.27

ug/l

0.22

103

1351

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

316

1546

1.47

9.22

1.1

—

(3005033) Fetal Nuchal fold Thickness US

561

0.28

9.22

1.1

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

230

1053

1.57

9.15

1.2

1.1

64.37

18.65

u/l

6.49

212

936

(3025018) Bordetella pertussis Ab [Titer] in Serum

959

0.45

9.15

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

128

2.74

9.10

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1781

10941

1.18

9.07

3.4

2.7

0.50

0.25

e6/l

7.00

1757

10695

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

265

2.16

9.01

1.1

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

167

2.49

8.93

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

179

2048

0.62

8.88

1.2

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3182

20406

1.13

8.85

2.1

1.7

1.82

1.51

44.56

2573

17663

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

193

856

1.62

8.79

1.6

—

(40768446) Kidney Pathology biopsy report

177

768

1.65

8.78

1.6

—

(3009992) Blasts/100 cells in Bone marrow

11.07

8.75

1.7

1.5

25.76

8.91

1.12

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

182

2.40

8.73

1.2

105.65

104.21

ug/l

0.03

110

(3002523) Influenza virus A Ag [Presence] in Specimen

180

2048

0.63

8.73

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

472

2507

1.35

8.65

1.3

1.2

3.89

3.90

u/ml

0.00

230

1112

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

182

799

1.63

8.64

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

518

4865

0.76

8.54

1.3

7.37

6.64

u/ml

0.16

772

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

140

575

1.75

8.50

1.2

1.1

—

(40768793) Breast Pathology biopsy report

434

4167

0.74

8.37

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

432

4149

0.74

8.35

1.2

1.86

15.35

u/ml

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

135

2.60

8.27

1.5

38.05

39.61

0.08

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

135

556

1.74

8.14

11.4

7.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

232

2463

0.67

8.12

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

380

3704

0.73

8.12

1.3

1.2

49.13

43.66

u/ml

0.24

354

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

515

4804

0.76

8.09

1.3

6.16

5.11

u/ml

0.12

497

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.41

7.98

1.6

1.4

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

4.00

7.91

9.0

10.5

—

(3046861) Legionella sp Ag [Presence] in Urine

106

2.77

7.81

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

254

2.09

7.69

1.4

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

127

523

1.74

7.69

1.4

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

483

0.30

7.67

1.2

1.1

—

(3012565) Volume of 24 hour Urine

220

1042

1.52

7.61

2.3

2.2

1684.80

2004.13

3.54

195

912

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

888

5207

1.23

7.55

1.7

2.0

12.99

11.10

mg/l

4.66

804

4827

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

160

2.37

7.46

7.3

4.9

—

(40757494) Bilirubin.total [Moles/volume] in Blood

241

1170

1.48

7.42

3.0

2.0

45.45

21.01

umol/l

0.92

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

3.92

7.41

9.3

41.38

47.87

0.37

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

165

2.35

7.41

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

229

2391

0.68

7.39

1.2

—

(3042517) Benzodiazepines panel - Urine

102

2.74

7.30

2.9

2.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

341

1771

1.38

7.27

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

171

2.30

7.27

1.1

—

(3015183) Erythrocyte sedimentation rate

730

0.44

7.25

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

132

0.00

7.19

0.0

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

509

0.34

7.17

1.7

1.9

6.79

8.98

mg/l

1.13

406

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

276

2.00

7.17

1.0

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

281

1.99

7.16

1.4

1.3

49.72

52.54

0.18

123

(3010838) Calcium [Moles/time] in 24 hour Urine

404

3827

0.75

7.16

1.6

1.9

4.29

5.00

mmol/24h

3.26

330

3346

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

132

563

1.68

7.09

1.4

1.2

30.43

21.65

0.79

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

841

0.48

7.08

1.0

1.1

4.97

6.31

u/ml

0.19

121

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

108

2.65

7.07

7.1

7.9

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

147

2.39

7.02

1.1

1.3

24.89

11.17

pmol/l

2.10

126

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

221

1068

1.48

6.99

1.8

2.42

2.70

u/field

0.23

162

742

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

339

1.88

6.98

3.2

2.8

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

366

1939

1.36

6.92

1.5

1.9

995.56

2435.56

titre

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.15

6.88

1.1

0.89

1.54

u/field

0.72

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

218

2.10

6.83

1.6

1.2

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

4.25

6.77

1.4

1.3

0.60

0.76

u/field

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

219

2.09

6.76

1.6

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

219

2.09

6.76

1.6

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

296

2908

0.73

6.74

1.6

1.5

67.78

58.40

4.45

201

1829

(21491868) Cryoglobulin [Mass/volume] in Serum

147

654

1.61

6.73

1.2

0.25

0.78

g/l

1.44

(3024869) Neuronal Ab [Presence] in Serum

397

1.79

6.62

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.13

6.60

1.1

1.0

247.57

277.07

nmol/l

0.37

(3022475) Manganese [Moles/volume] in Blood

105

2.59

6.46

1.1

1.3

—

(40768797) Stomach Pathology biopsy report

3749

29145

0.91

6.45

1.3

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

468

2598

1.29

6.43

1.2

3.01

4.29

u/ml

1.23

172

890

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

263

1.96

6.41

1.0

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

2.94

6.40

1.8

1.4

252.13

178.09

ug/g

0.73

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.87

6.13

1.1

1.2

4341.86

1903.26

ng/l

1.13

(3012898) Urea [Moles/volume] in Urine

190

2.11

6.09

1.3

1.4

130.11

171.48

mmol/l

2.03

170

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

774

0.51

6.00

1.1

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.24

5.99

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1028

0.58

5.86

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

1117

0.59

5.84

1.7

1.5

4.06

3.76

0.12

225

(3038071) Oxygen [Partial pressure] in Mixed venous blood

112

484

1.66

5.82

11.5

7.5

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

4.06

5.75

1.0

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

311

1.82

5.68

2.1

2.9

70.11

59.52

mg/l

0.17

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.60

5.67

1.0

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

451

4077

0.79

5.66

1.2

6.30

5.87

u/ml

0.04

300

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

109

2.43

5.58

1.1

1.0

4.56

2.13

u/l

—

(3034426) Prothrombin time (PT)

124

557

1.60

5.55

1.2

—

(3007463) Buprenorphine [Presence] in Urine

4.09

5.47

2.0

8.4

—

(3020650) Glucose [Presence] in Urine

485

0.41

5.44

1.9

1.4

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.80

5.35

23.1

11.7

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

107

2.41

5.34

1.5

1.4

2.17

1.53

0.29

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.27

5.33

1.7

2.0

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

125

2.29

5.33

1.5

14.27

11.82

0.30

(3019420) Tryptase [Mass/volume] in Serum or Plasma

953

0.58

5.28

1.3

1.6

7.34

9.40

ug/l

1.62

863

(3024666) Lithium [Moles/volume] in Serum or Plasma

164

794

1.48

5.27

11.1

12.6

0.69

0.62

mmol/l

2.17

147

723

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

117

2.33

5.24

1.4

1.2

46.67

44.64

mg/l

0.17

(3004775) Volume in Urine collected for unspecified duration

330

1802

1.31

5.21

1.9

2.3

691.34

685.77

0.07

182

1233

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

243

1.89

5.18

1.1

1.3

8.55

269162.95

nmol/l

1.54

201

(3000494) Fungus identified in Specimen by Culture

3612

23969

1.09

5.15

1.8

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

110

490

1.61

5.13

1.4

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

896

5467

1.18

5.12

5.6

4.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

175

2.05

5.08

3.0

2.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

334

3088

0.77

5.08

1.3

0.39

0.22

nmol/l

0.59

222

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

262

2502

0.75

5.06

1.1

—

(3016750) Collection duration of Urine

249

1310

1.36

5.06

1.9

2.2

499.10

499.93

min

0.04

153

973

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

957

0.60

5.01

1.4

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

7.88

5.00

1.5

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.64

4.99

1.3

1.4

0.75

1.11

u/field

1.57

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

288

1.79

4.97

1.2

1.3

40.98

43.68

mg/l

0.18

244

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

915

0.59

4.89

1.2

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

266

2519

0.75

4.87

1.1

10.78

11.32

au/ml

—

116

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.75

4.83

1.2

1.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

336

3080

0.78

4.80

1.3

1.21

1.82

nmol/l

0.36

314

2962

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.57

4.76

6.5

9.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

880

5398

1.17

4.74

2.1

2.3

194.34

99.23

ug/min

4.17

483

3173

(3001186) Copper [Moles/volume] in Serum or Plasma

390

1.65

4.71

1.3

1.2

16.69

16.64

umol/l

0.03

351

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.01

4.71

1.7

2.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

168

840

1.43

4.63

1.1

1.41

1.05

u/l

1.00

418

(3038026) Centromere Ab [Units/volume] in Serum

169

1700

0.71

4.61

1.2

44.14

57.15

u/ml

0.26

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

115

2.24

4.61

2.8

2.9

1.89

2.22

mg/l

0.54

(40762814) Titanium [Mass/volume] in Blood

481

0.46

4.61

1.6

2.3

5.96

3.39

ug/l

—

172

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

106

482

1.58

4.59

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

519

3046

1.22

4.56

1.1

1.3

156.35

206.96

miu/ml

2.05

1212

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

127

1335

0.68

4.45

1.9

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

516

4469

0.82

4.43

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

165

1654

0.71

4.43

1.2

46.17

40.69

u/ml

0.13

117

(4146454) Self-monitoring of blood glucose

296

2723

0.78

4.40

2.5

2.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

328

2977

0.79

4.36

1.8

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

251

0.28

4.31

1.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

147

1494

0.70

4.29

1.1

1.2

11.01

9.33

mmol/l

2.96

134

1416

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.71

4.26

3.4

5.3

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

166

1650

0.72

4.25

1.2

43.55

87.88

u/ml

1.49

(3012494) Peanut IgE Ab [Units/volume] in Serum

385

0.43

4.21

1.0

1.1

0.97

1.52

u/ml

0.33

196

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

154

777

1.42

4.10

1.1

883.45

708.89

ng/l

0.12

187

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1298

8279

1.13

4.07

1.6

1.9

37.71

39.25

u/l

1.66

1100

7207

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.36

4.05

1.0

1.1

22.53

21.46

0.62

(3005082) Progesterone [Moles/volume] in Serum or Plasma

156

0.23

4.04

1.0

1.3

29.80

28.80

nmol/l

—

128

(40763791) Oxygen content in Venous blood by calculation

2.90

4.03

7.3

5.1

11.30

11.94

ml/dl

0.22

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

199

1054

1.35

3.98

1.5

1.7

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

7.16

3.97

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

178

0.28

3.95

7.1

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

314

2825

0.79

3.92

1.3

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

301

1695

1.27

3.89

2.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

202

1077

1.34

3.88

2.1

2.2

221.47

86.50

ug/min

0.59

238

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

230

2139

0.77

3.78

1.6

1.5

22.20

29.76

3.21

159

1300

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

324

1849

1.26

3.76

1.2

1.1

90.42

96.62

3.59

310

1716

(3049233) Organic acids panel - Urine

6.44

3.74

1.2

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

315

0.41

3.72

1.2

1.4

10.37

9.22

mmol/l

0.86

298

(3028679) Herpes simplex virus Ab [Presence] in Serum

146

744

1.41

3.72

1.1

1.2

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.54

3.71

4.5

6.0

1.25

1.09

mg/l

0.25

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

127

2.03

3.68

1.5

1.4

22.89

21.65

mmol/l

0.48

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

740

6106

0.86

3.64

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

446

2647

1.21

3.60

3.4

2.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

502

0.54

3.56

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

666

5512

0.86

3.44

1.7

1.6

19888.52

13799.35

e6/l

1.91

479

3976

(44816559) Phosphatidylethanol [Mass/volume] in Blood

378

3281

0.82

3.42

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

293

0.42

3.42

1.2

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

699

5761

0.87

3.41

1.5

1.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

225

1.72

3.37

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.47

3.36

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

5.37

3.34

1.1

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

168

1.83

3.32

3.0

2.1

—

(3021788) Differential panel - Synovial fluid

493

4162

0.85

3.29

1.6

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

143

1388

0.74

3.25

1.3

1.4

0.16

0.24

nmol/l

3.28

997

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

449

1.48

3.20

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

341

0.48

3.14

1.1

1.0

12.52

9.28

u/ml

—

173

(3017509) Phencyclidine [Presence] in Urine

101

2.06

3.11

1.9

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

153

1459

0.75

3.11

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

141

1.88

3.10

1.2

—

(3006270) Folate [Moles/volume] in Blood

274

1574

1.25

3.09

1.2

329.05

349.07

nmol/l

0.82

219

1304

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

204

0.35

2.98

1.7

1.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

901

7227

0.89

2.95

1.2

1.44

0.90

u/ml

0.44

643

(3019768) Coxiella burnetii Ab [Presence] in Serum

114

1.95

2.90

1.3

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

134

1287

0.74

2.89

1.3

1.30

1.48

u/ml

0.14

731

(4034850) Laboratory test

813

6552

0.89

2.89

16.3

9.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

236

1.64

2.89

2.8

2.5

0.48

0.59

u/field

0.44

236

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

611

0.63

2.86

1.2

0.35

0.31

g/l

1.77

491

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.00

2.85

0.0

1.1

—

2.26

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

328

1.53

2.82

1.5

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

181

1001

1.30

2.81

2.8

5.5

640.47

4574.64

u/ml

0.57

183

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

294

1.56

2.81

3.6

5.4

77.02

42.75

ug/min

2.45

241

(3028468) Fragments [Presence] in Blood by Light microscopy

4.77

2.79

1.0

2.7

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

381

2290

1.19

2.79

1.8

2.2

1.60

6.29

titre

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.77

2.78

1.6

2.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

358

3052

0.84

2.75

1.1

71.39

4019.79

iu/ml

0.56

609

(3004616) Nuclear Ab [Presence] in Serum

280

2442

0.82

2.75

1.2

1.3

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

158

1.77

2.74

1.1

1.2

19.71

20.36

—

(3011288) Drugs identified in Urine by Screen method

370

2225

1.19

2.71

4.9

3.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

390

1.47

2.69

1.4

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

306

1809

1.21

2.68

2.4

2.0

2921.03

3465.78

u/l

0.09

625

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

574

0.64

2.66

1.2

122.33

111.70

1.69

505

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

129

1229

0.75

2.66

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

890

0.71

2.66

1.1

1.3

6.14

6.08

mmol/l

0.26

835

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

309

2657

0.83

2.63

1.3

—

nmol/l

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

5.01

2.58

1.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

5.01

2.58

1.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

129

1216

0.76

2.49

1.2

—

(3018291) Platelet Ab [Presence] in Serum

3.03

2.42

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

138

1.76

2.41

1.2

1.1

12.47

9.20

u/l

0.47

138

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

209

1.61

2.41

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

524

0.64

2.39

1.1

—

(3032641) Amino acids panel - Urine

7.16

2.39

1.0

1.4

—

(3051339) Copper [Moles/volume] in Blood

1.95

2.38

1.1

1.2

16.72

16.49

umol/l

0.07

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.95

2.38

1.1

1.7

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

5.37

2.37

1.2

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

5.37

2.37

1.2

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

5.37

2.37

1.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

5.37

2.37

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

290

1.51

2.35

3.8

5.3

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

2.30

0.0

1.0

—

0.30

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

184

1.63

2.29

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2247

17082

0.94

2.26

5.0

2.5

55.43

63.77

ml/min/173m2

16.27

989

6800

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

254

2184

0.83

2.23

1.3

1.2

—

36.62

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.72

2.14

1.2

—

(40761536) Microorganisms panel - Urine sediment

2437

16495

1.06

2.12

5.3

4.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

2.12

0.0

6.2

—

0.29

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

695

0.71

2.12

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

322

2699

0.85

2.12

1.4

1.3

280.34

333.65

pmol/l

0.65

259

2320

(3039162) Centromere protein B Ab [Units/volume] in Serum

278

2358

0.84

2.11

1.2

64.00

58.72

u/ml

0.16

157

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

2.09

0.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.63

2.04

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

148

1330

0.80

2.03

1.6

2.0

16.18

16.68

nmol/l

0.18

131

1246

(3003129) Base excess in Capillary blood by calculation

647

0.71

2.02

2.1

1.7

1.65

0.48

mmol/l

0.87

620

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

269

1622

1.19

2.01

1.5

1.6

27.58

22.85

u/ml

0.71

321

(3050794) Legionella sp Ab [Presence] in Serum

180

1.59

2.00

1.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.11

1.98

1.4

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

1.93

0.0

1.3

—

2.20

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.06

1.92

5.6

2.8

21.30

20.22

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

442

0.66

1.86

1.3

1.8

—

(3013637) Mi-2 Ab [Presence] in Serum

527

0.69

1.85

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

527

0.69

1.85

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

527

0.69

1.85

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

527

0.69

1.85

1.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.81

1.83

1.1

1.7

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

590

0.72

1.79

1.6

1.3

25.18

38.78

2.10

385

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

531

0.70

1.78

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

3.13

1.77

1.1

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1138

7558

1.08

1.77

1.3

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

136

1.63

1.75

2.5

2.9

1479.78

15.67

pmol/l

0.53

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

751

0.75

1.73

1.0

1.1

95.60

98.76

0.38

584

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

378

1.36

1.73

1.5

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

3.98

1.67

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

188

1609

0.84

1.66

4.1

5.1

125.35

114.43

u/ml

0.09

474

(3011985) Renin [Units/volume] in Plasma

354

2884

0.88

1.65

1.6

1.4

74.04

60.21

mu/l

0.72

304

2549

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

144

1.59

1.65

1.2

1.6

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

111

1.68

1.63

1.0

1.1

292.79

57.09

u/l

0.41

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

153

0.47

1.63

2.0

2.3

13.43

20.75

mg/l

—

141

(37019676) Renin [Units/volume] in Plasma --supine

2.05

1.58

1.0

1.1

61.81

56.36

mu/l

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

397

1.34

1.58

7.8

6.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

429

1.32

1.55

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

442

1.31

1.54

2.2

2.5

7.27

7.56

mmol/l

0.23

272

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.00

1.54

0.0

1.0

—

0.22

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

129

748

1.24

1.52

1.2

1.1

3.94

15.84

u/ml

1.19

(3037522) Nuclear Ab [Titer] in Serum

3382

25133

0.96

1.51

1.3

493.84

535.63

titre

0.76

792

5285

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

148

0.48

1.50

2.0

2.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

341

2760

0.88

1.48

1.4

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

166

1.51

1.47

1.1

1.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.69

1.45

1.4

1.5

0.31

1.46

mg/l

2.07

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

526

0.73

1.45

1.9

1.8

4.94

5.03

ug/l

0.01

342

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.92

1.45

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

2.86

1.44

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

244

1.41

1.44

2.0

2.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.43

1.43

1.0

0.03

0.07

u/ml

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

388

2479

1.12

1.41

1.2

1.1

108.52

118.02

5.13

363

2211

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.73

1.41

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

401

2568

1.12

1.40

1.2

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.51

1.40

1.0

1.3

—

(3017400) Magnesium [Moles/volume] in Urine

2.24

1.39

1.0

2.10

2.36

mmol/l

—

(3013466) aPTT in Blood by Coagulation assay

1.70

1.36

1.3

1.1

36.63

37.50

0.16

(3001686) Cold agglutinin [Titer] in Serum or Plasma

376

1.31

1.36

1.2

1.4

53.62

230.00

titre

1.42

(36303858) Crystals [Presence] in Urine

2.22

1.36

1.0

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.07

1.30

1.0

1.1

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.65

1.29

1.4

1.5

0.94

2.12

mg/l

1.17

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.65

1.29

1.4

1.5

0.57

1.65

mg/l

1.15

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.65

1.29

1.4

1.5

1.21

1.13

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.65

1.29

1.4

1.5

1.38

1.04

mg/l

0.14

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

1.65

1.29

1.4

1.5

0.90

2.82

mg/l

1.74

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.65

1.29

1.4

1.5

0.55

1.92

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.65

1.29

1.4

1.5

5.34

3.67

mg/l

0.24

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

1.65

1.29

1.4

1.5

1.49

2.24

mg/l

0.63

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.65

1.29

1.4

1.5

2.87

2.84

mg/l

0.01

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

176

0.57

1.29

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

555

0.76

1.28

1.3

1.2

3.56

2.92

umol/l

0.62

511

(3026389) Candida sp identified in Specimen by Organism specific culture

428

2769

1.11

1.28

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

149

1.49

1.26

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.29

1.26

1.1

1.2

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.70

1.22

1.0

1.1

6.08

5.68

mmol/l

0.12

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

104

1.58

1.22

1.1

—

(3000285) Sodium [Moles/volume] in Blood

311

0.69

1.21

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

372

1.29

1.19

1.1

—

(3049717) Cytology report of Urine Cyto stain

1230

9301

0.94

1.17

2.6

2.8

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

152

1.46

1.16

1.1

—

(3044941) Cell count panel - Synovial fluid

444

3482

0.91

1.14

1.5

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

176

1457

0.86

1.14

2.9

2.4

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.87

1.10

1.9

3.8

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

119

0.54

1.10

1.2

—

(3016879) Cocaine [Presence] in Urine

492

3234

1.09

1.10

3.5

2.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

131

793

1.18

1.08

1.6

13.29

6.36

nmol/l

0.83

112

665

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.48

1.07

1.2

1.1

8.58

8.57

mmol/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

148

0.58

1.06

1.4

1.5

—

(3003694) ABO and Rh group [Type] in Blood

7234

50834

1.02

1.03

1.4

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.56

1.02

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

241

0.68

1.02

1.6

1.7

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.76

1.01

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

172

0.62

1.01

1.1

1.4

0.10

0.16

nmol/l

—

115

(3009015) Lactate [Moles/volume] in Synovial fluid

274

0.71

1.01

1.2

1.3

8.61

6.32

mmol/l

1.09

129

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

243

1949

0.89

1.00

1.2

1.3

1.47

1.42

nmol/l

0.28

215

1772

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

256

1.31

1.00

2.1

—

(3000034) Microalbumin [Mass/volume] in Urine

254

2028

0.90

0.97

3.0

3.1

88.55

40.80

mg/l

1.23

194

1465

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.39

0.97

1.0

3.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

221

0.68

0.96

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

181

1138

1.14

0.95

1.2

1.4

1.13

1.24

nmol/l

0.82

139

879

(3041184) Isoniazid [Presence] in Urine

1.93

0.94

3.1

2.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

506

3901

0.93

1.4

30.37

33.69

iu/l

1.51

400

3323

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

257

2040

0.90

0.91

1.1

1.43

2.16

iu/ml

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

333

0.75

0.90

1.2

1.4

76.00

72.15

0.77

321

(3006462) Nitrate [Presence] in Urine

121

1006

0.86

0.89

3.6

3.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

243

1.30

0.87

1.8

2.0

15.83

17.49

umol/l

0.39

243

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

546

0.81

0.86

1.5

0.45

0.37

ug/l

0.54

350

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

330

0.76

0.85

1.2

1.4

575.03

1147.71

mu/l

0.77

318

(3019832) Treponema pallidum Ab [Presence] in Serum

986

7404

0.95

0.81

1.5

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

558

1.18

0.81

1.4

1.7

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

104

1.45

0.80

1.2

1.3

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.50

0.78

1.0

1.1

145.43

163.14

pmol/l

—

(3016330) Potassium [Moles/time] in 24 hour Urine

300

0.76

0.77

1.2

—

85.49

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.62

0.74

1.0

1.1

0.63

0.05

g/l

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

369

2847

0.93

0.74

2.7

2.1

31.33

25.90

mg/l

0.94

124

738

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.86

0.74

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

224

1454

1.10

0.74

1.3

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

174

1.32

0.74

1.2

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

10554

76394

0.98

0.73

3.5

2.8

335.28

133.64

ug/l

87.72

9733

69765

(3023511) Choriogonadotropin [Units/volume] in Urine

119

745

1.14

0.72

1.4

1.3

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

150

1.34

0.71

1.5

1.7

1.18

0.72

0.36

120

(3006969) Lambda light chains [Mass/volume] in Urine

1.64

0.71

1.0

1.1

0.20

0.01

g/l

—

(3041806) Other cells [#/volume] in Blood by Manual count

140

0.66

0.71

1.9

1.5

—

(3036005) Urine sediment comments by Light microscopy Narrative

1.88

0.69

1.0

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.53

0.68

1.0

1.3

0.15

9.17

u/ml

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1492

11049

0.96

0.67

3.1

3.3

4.01

4.46

pmol/l

41.66

1293

9805

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

108

681

1.14

0.62

1.1

1705.27

1562.66

miu/ml

0.57

108

681

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

562

0.85

0.61

3.7

6.6

61.92

71.67

1.53

455

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

810

5549

1.05

0.61

1.5

1.6

1.92

10.38

iu/ml

1.33

237

1170

(3002079) Sodium [Moles/time] in 24 hour Urine

111

897

0.89

0.61

1.1

1.2

155.24

165.98

mmol/24h

0.56

111

897

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

176

0.73

0.61

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

103

835

0.88

0.60

2.6

3.1

19.59

25.75

mu/l

0.67

787

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.60

0.58

1.0

0.07

0.82

u/ml

—

(3013762) Body weight Measured

0.57

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.56

0.57

1.0

1.4

1260.84

472.54

nmol/l

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

214

1410

1.09

0.56

1.3

371.30

428.90

titre

0.09

109

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

125

1.32

0.56

1.2

1.8

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.65

0.56

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

208

1372

1.09

0.54

1.2

1.3

96.67

73.65

titre

0.34

115

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

327

1.18

0.54

2.6

3.1

124.71

126.47

ng/l

0.01

118

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

204

1345

1.09

0.54

1.1

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

130

840

1.11

0.53

1.5

1.4

34.01

24.73

umol/l

2.01

122

795

(3030313) Adrenal Ab [Titer] in Serum

1.37

0.52

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

542

1.14

0.52

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.66

0.52

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

356

1.17

0.51

3.3

2.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

203

1343

1.08

0.51

1.1

1.2

—

(3024316) Viscosity of Plasma

1.34

0.50

2.2

1.9

1.51

1.72

mpas

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

204

1352

1.08

0.49

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

203

1346

1.08

0.49

1.1

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

168

0.77

0.47

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

577

4310

0.96

0.46

1.4

1.8

3.28

11.03

iu/l

1.41

131

1453

(3051101) Glucose [Moles/volume] in Cord blood

409

0.86

0.46

5.0

6.1

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.58

0.46

1.0

443.40

350.55

u/l

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.43

0.46

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

203

1351

1.08

0.45

1.1

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

280

2130

0.94

0.45

1.4

184537.72

125092.05

e6/l

0.56

189

1464

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

203

1352

1.08

0.45

1.1

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

148

1152

0.92

0.45

1.0

1.1

13.66

5.42

nmol/l

0.38

231

(3001556) Androgen free Index in Serum or Plasma

0.65

0.43

1.2

1.3

—

(3018133) Calcium [Moles/volume] in Urine

276

1.17

0.42

1.4

1.7

2.34

2.59

mmol/l

0.35

248

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.56

0.42

1.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.0

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

1.40

0.42

1.3

1.0

—

23.24

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.0

—

0.52

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.37

0.42

1.1

1.0

0.05

mg/l

0.21

(43055514) Macroprolactin [Presence] in Serum or Plasma

242

0.83

0.40

1.1

1.5

—

(3001729) Color of Synovial fluid

178

1.21

0.40

1.5

1.6

—

(46235168) Fasting glucose [Moles/volume] in Blood

187

0.80

0.40

2.1

1.4

9.00

6.23

mmol/l

5.42

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.43

0.39

1.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

194

0.81

0.39

1.0

107.84

83.79

ug/l

0.80

139

(3024263) Appearance of Synovial fluid

153

1179

0.93

0.38

1.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.38

0.37

3.0

2.0

—

(3044009) aPTT.lupus sensitive (LA screen)

147

1.22

0.37

1.4

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6107

44145

0.99

0.37

1.7

13128193.90

35179154.92

pmol/l

3.79

5058

35837

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

106

696

1.09

0.36

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

452

1.11

0.34

1.2

92.02

61.25

mu/l

0.64

329

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

154

1178

0.94

0.33

4.6

6.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

113

874

0.93

0.33

3.0

2.4

—

(3034614) HLA Ag [Interpretation]

1.30

0.33

1.3

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

136

1043

0.93

0.32

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.70

0.31

1.1

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

165

0.82

0.31

1.2

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

130

995

0.94

0.30

1.1

1.12

1.07

ratio

1.46

356

(3036670) Protein [Mass/volume] in Synovial fluid

719

0.93

0.29

1.2

1.3

38.55

40.67

g/l

0.73

382

(3029075) Extractable nuclear Ab panel - Serum

533

1.09

0.29

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

608

4230

1.03

0.28

1.5

1.7

0.92

0.82

nmol/l

1.88

474

3541

(3051387) C reactive protein [Mass/volume] in Capillary blood

583

4296

0.97

0.28

4.3

3.4

37.49

25.44

mg/l

9.10

388

2642

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

119

1.20

0.28

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

527

1.09

0.28

1.1

1.2

564.02

284.43

pmol/l

0.66

380

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

315

0.89

0.28

1.1

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

497

3449

1.03

0.28

3.5

2.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.78

0.26

1.1

1.0

0.03

0.15

u/ml

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.24

0.25

1.3

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

517

3598

1.03

0.25

1.5

1.8

398.03

293.59

mu/l

3.92

483

3303

(3045683) HLA typing for celiac disease panel - Blood or Tissue

133

900

1.06

0.24

1.1

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

629

1.07

0.24

1.3

1.4

17.80

15.58

pmol/l

0.90

522

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.27

0.24

1.0

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

212

0.88

0.22

2.8

2.9

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.21

0.0

1.2

—

1.99

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

211

0.88

0.21

5.5

5.9

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.75

0.21

1.1

—

(3028300) Cannabinoids [Presence] in Urine

498

3478

1.03

0.21

3.6

2.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

464

3406

0.97

0.20

3.5

2.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

531

3717

1.02

0.19

4.9

3.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

128

960

0.95

0.19

1.6

1.7

23.52

11.26

umol/l

1.80

101

685

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

581

1.06

0.18

1.0

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

297

0.92

0.17

2.1

2.6

53.83

70.45

pmol/l

0.65

263

(3027008) Opiates [Presence] in Urine

494

3468

1.02

0.15

3.5

2.0

—

(3036603) Volume of Urine

212

1472

1.03

0.15

1.6

1.5

1791.54

1911.69

1.12

204

1423

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

117

873

0.96

0.15

1.1

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

235

0.91

0.15

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.15

0.15

1.3

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

315

1.07

0.14

1.5

1.8

56.02

56.73

pmol/l

0.02

257

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

322

1.07

0.13

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

279

1952

1.02

0.13

1.3

1.5

52.38

25.79

iu/ml

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

307

2151

1.02

0.13

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

540

1.05

0.13

1.3

122.07

129.14

nmol/l

0.11

384

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

365

1.06

0.13

3.3

2.3

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

423

0.95

0.12

1.3

1.2

91.89

26.73

mg/l

0.32

316

(3004446) Plasmodium sp identified in Blood by Light microscopy

158

0.91

0.12

2.4

2.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

224

0.93

0.11

12.0

8.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

21757

155921

1.00

0.11

17.3

6.9

111.09

74.68

u/l

307.65

20960

146517

(3019174) dRVVT (LA screen)

144

1.09

0.11

1.4

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

213

1558

0.98

0.10

1.0

589.11

742.62

ng/l

6.95

145

1042

(3013166) Neutrophils/100 leukocytes in Synovial fluid

674

1.03

0.08

1.5

1.4

72.14

55.23

5.98

582

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

140

0.92

0.08

1.1

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

476

3371

1.01

0.07

1.1

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

393

1.04

0.07

2.6

1.4

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.10

0.07

1.6

1.5

0.00

0.33

u/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

213

1549

0.98

0.07

1.0

553.69

310.29

ng/l

0.81

155

1074

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.10

0.06

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

215

1560

0.99

0.06

1.0

44.54

43.39

ng/l

0.14

151

1066

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

552

1.02

0.05

1.5

1.6

12.51

8.93

ug/l

4.48

552

(3020491) Glucose [Moles/volume] in Blood

203

1435

1.01

0.05

2.3

1.9

8.02

7.03

mmol/l

2.95

158

973

(3011325) HIV 1+2 Ab [Presence] in Serum

1.09

0.04

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

461

0.98

0.03

1.2

1.1

0.75

0.82

umol/24h

0.16

214

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

214

1.04

0.03

1.0

1.1

2.14

1.73

umol/24h

0.90

214

(3027570) Oxalate [Moles/time] in 24 hour Urine

115

1.06

0.03

1.7

1.3

463.65

331.50

umol/24h

1.01

115

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

135

0.95

0.02

1.4

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

116

1.05

0.02

1.2

2.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

280

1.02

0.02

1.6

1.5

—

(3002619) Bacteria identified in Specimen by Culture

443

0.99

0.01

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

282

0.99

0.00

1.4

1.6

—

(40758358) Immune stain study

1.03

0.00

1.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

125

0.97

0.00

1.4

1.6

175.17

203.29

ng/l

1.22

111

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

164

1173

1.00

0.00

1.7

1.5

9.62

5.80

u/l

1.60

141

986

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

241

1.01

0.00

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

143

1.00

0.00

1.1

5.4

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

225

1.02

0.00

1.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.0

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.95

0.00

1.2

1.1

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.91

-0.00

1.0

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

0.91

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded (not available in FinRegistry).

Relationships between endpoints

↥

Index endpoint: DEATH – Any death

GWS hits: -

This endpoint is excluded (not available in FinRegistry).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Any death

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints